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CHAPTER 1

INTRODUCTION

1.1

Motivation

Discovery of a drug is a very complex but a mandatory process. It almost takes
an average of 12-15 years; from the identification of a new drug to its launch into
the pharmaceutical market. It is a very slow process and there are many challenges
faced during the timeline as it is time consuming, data intensive, and involves an
expensive developmental process which demands rigorous lab testing with high rates
of uncertainty that the given drug will succeed. Therefore, it highlights the crucial
need for machine learning (ML) methods to automate and hasten the drug discovery
pipeline for improved healthcare and assist clinicians to make informed decisions
for in-vitro testing. Initiation of ML techniques in the preliminary stages of drug
discovery and development (right from the initial screening of drug compounds to
predicted success rate based on biological factors) has provided a better solution to
the challenges faced and also improved decision-making purposes in healthcare and
pharmaceutical industry [1] [2]. According to Accenture data, key clinical health ML
applications can potentially create $150 billion in annual saving for United States
health care sector by 2026. By utilizing advanced ML techniques, we can predict
1

the potential drug- candidate protein conformations that can successfully bind to
the target protein and identify their data patterns which further aid the prediction
analysis of binding state for any new molecular conformation. Later, in-vitro and
in-vivo testings are performed on these identified drug candidates under pre-clinical
lab trials thus determining a precise binding with the least amount of time and cost
expended with minimal pre-clinical lab trials as well as reduced failure rates at much
early-stages in the drug discovery pipeline. As a result, the research of new ML
techniques for drug discovery is of utmost importance and bears the consequences in
the health care domain for disease diagnosis and improved patient-care.

1.2

Literature Survey

In literature few commonly used ML techniques based on clustering for protein
conformational selection include root mean squared deviation (RMSD) clustering,
perron cluster analysis (PCCA+) and Markov-clustering (MCL) methods. RMSD is a
least squares approach that computes protein conformational RMSD values to generate
clusters or protein conformational states based on a user-defined threshold [3] [4].
PCCA+ is a fuzzy clustering algorithm that performs clustering on the eigenvalues of
the protein conformational transitions. MCL is a graph-based clustering algorithm
that uses the probability of a random walker to transition to a particular sequence of
states. Random walks are calculated using Markov chains. They represent a sequence
of possible events in which the probability of each event depends only on the state
attained in the previous event.
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Strecker and Meyer performed clustering methods such as K-Means and
hierarchical clustering (with average linkage) analysis on the cluster representatives
to measure the docking performance in terms of binding pose prediction, screening
utility and scoring accuracy [5]. They claimed that the cluster representatives were
obtained using RMSD matrix. The sum of RMSD values for each cluster member to
all the other cluster members was calculated and thereafter, the structure which had
the smallest sum was chosen as the cluster representative. There are also other mutual
information-based methods [6] [7] and dimensionality reduction methods proposed for
information extraction [8].
However, the performance of docking is highly dependent on protein structures
selected, therefore a ProSelection algorithm was introduced by Nanyi , Lirong and
Xiang. It is a docking preferred-protein selection technique. This technique filters out
weak protein selectors and considers only strong protein selectors. Strong selectors are
defined as the structures that exhibit good statistical performance in distinguishing
active ligands from inactive ligands. They have performed statistical methods such
as t test and Mann Whitney U test to distinguish the strong selectors from weak
selectors based on the docking score distribution [9]. However, statistical approaches
such as the ProSelection algorithm doesn’t work for targets which do not have enough
active ligands. Therefore, ML algorithms can be an alternative solution to predict the
potential drug protein conformation.
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1.3

Research Problem

Most of the datasets in the biomedical field especially that are available for the
study of drug discovery application and protein conformational selection suffer from
statistical ill-conditioning issues such as class imbalance problem. However, the current
ML methods do not address the caveats of statistically ill-conditioned real-world data
availability. In this class imbalance problem, the smaller group of potential drug
candidate protein conformations is dominated by the larger population of non-drug
candidate protein conformations (the number of instances of potential drug candidate
protein are far less than the instances of non-potential drug candidate protein).
Consequently, most of the ML techniques employed for data-learning on such a biased
population dataset will result in a high risk that the smaller population of potential
drug candidate protein conformations (minority class samples) will be misclassified/
misidentified as the non-drug candidate protein conformations. Furthermore, in
practice this could lead to serious effects where the clinicians arrive at erroneous
conclusions of the probable subset of proteins that need further lab-testing and
analysis, thereby, drastically reducing the impact and reliability of analytical solutions
for drug discovery application.

1.4

Our Approach

In this thesis, we have designed a drug discovery system that can overcome
our research problem of protein conformational selection by implementing a two-stage
sampling-based classifier system. The system uses sampling strategies to study the
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class imbalance problem, to maximize the detection of potential drug-candidate
conformations and recommend them to the clinicians for further in-vitro analysis. The
system also identifies the non-drug candidate conformations of a protein and discards
them during the clinical trials thus reducing the substantial investment of resources.
The system internally implements a clustering-based K-Means undersampling technique
and Synthetic Minority Over-sampling Technique (SMOTE) techniques as the sampling
strategies while designing our system. The K-Means clustering-based undersampling
technique plays a vital role in preserving most of the important information of
the conformations that belong to the non-drug candidate class thus removing the
conformations that are less important in the dataset.
The novel contributions of this thesis are outlined as below:
• This research work studies the class imbalance problem in drug discovery
applications and how it affects the detection rates of potential drug candidate
conformations.
• It introduces new ML strategies and presents a case study to counter the class
imbalance problem and maximize prediction rates of potential drug candidate
molecular conformations for target protein ADORA2A and OPRK1.
• This work is a first to study the effects of class imbalance problem to design
a new comprehensive drug discovery system, which optimizes the detection of
non-drug candidate protein conformations that could be discarded and potential
drug-candidate protein conformations that should be retained for further in-vitro
analysis.
5

• Thus, the proposed drug discovery approaches can assist clinicians for expedited
informed decision-making during clinical trials and reduce the substantial
investment of resources to include time, cost and rigorous lab trials.

1.5

Thesis Organization

The remainder of the thesis is organized as follows. Chapter 2 covers brief
introduction on class imbalance problem, sampling strategies and various supervised
and unsupervised models involved in designing the drug discovery system. Chapter 3
presents the methodology of the proposed two-stage sampling-based classifier to identify
maximum number of potential drug candidate conformations that should be retained
for further in-vitro analysis and detection of non-drug candidate protein conformations
that could be discarded. Chapter 4 discusses the drawbacks of random undersampling
method and proposed an alternative method of undersampling; K-Means clustering
based undersampling technique. Chapter 3 and 4 also illustrate the computational
evaluation on biomedical datasets using the proposed methods. Chapter 5 discusses
about the statistical data patterns and distributions of the datasets ADORA2A and
OPRK1. Finally, in Chapter 6 we conclude the thesis with possible future directions
that could be explored.
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CHAPTER 2

BACKGROUND AND RELATED WORK

2.1

Drug discovery and Development

Drug discovery is the process of identification of specific disease-causing proteins
and highlights the research efforts to derive a new medication that targets these proteins.
The contemporary drug discovery and development-timeline is a complex process
that involves identifying a new medicine, right from target identification to an FDA
approval drug, takes an average of 12-15 years and cost more than $1 billion for
launching a finished product. Moreover, the process demands rigorous lab testing with
inflated failure rates of over 90% during clinical testing, where the identified potential
drug candidate proteins fail to succeed during various stages of developmental clinical
trials [10].
The core concept of drug discovery application involves a biological target which
is a protein within a living organism that binds with an entity such as ligand to achieve
a diverse functionality. In pharmacology, a ligand is a small substance that forms a
complex with a biomolecule to serve a biological purpose. In protein-ligand binding,
the ligand produces a signal by binding to a site on a target protein resulting in a
change of conformation of the target protein. The primary function of protein-ligand
7

binding is to design and develop an organic small molecule (drug) that activates the
functionality of a biomolecule such as a protein to achieve a therapeutic benefit to
the patient. Indeed, drug discovery can be infered as the process of identification of
small molecules that will bind selectively and safely to specific protein targets that
are responsible for diseases.

2.1.1

Drawbacks of drug development process
The major drawback of the drug development process is extreme rates of

uncertainty that a given drug will succeed. The prominent cause of these failures is
that the potential drug candidates often tend to bind to off-target proteins, instead of
only binding to their intended protein targets. This off-target drug binding can lead
to a spectrum of adverse effects ranging from lack of potency and selectivity to more
serious issues of drug toxicity. In recent research efforts to handle the toxicity issues,
besides prediction of potential drug candidates, proteins scientists are also interested
in prediction of off-target binding as off-target binding gives rise to toxicity [11]. A
ligand can become a safe and an efficacious drug on optimizing biophysical, structural
and chemical properties. There are very high attrition rates acquired during the
clinical phase of drug development lifecycle, As a consequence, the potential drug
candidates chosen are based on their physicochemical properties thereby, resulting in
fewer complications during the drug design process and lesser occurrence of off-target
binding phenomenon.
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2.1.2

Molecular Docking and Pre-clinical lab trials
Traditionally, discovery of small chemicals that bind to proteins are performed

through in-vitro procedure of potential ligands either from natural sources or synthetic
chemical libraries depending on their capacity to bind to different proteins using
a variety of biophysical and biochemical techniques. In-vitro drug design refers to
the technique of evaluating direct interaction between a ligand and a target protein
along with observing functionality of ligands on signaling pathway in the cell whereas,
in-vivo refers to the technique of providing a compelling evidence through preclinical
lab trials performed at the physiological level [12]. The advantages of in-vivo along
with in-vitro approach is that one can not only predict and assess binding affinity
of potential drug candidate to target protein, but also monitor the overall biological
activity of the chosen ligand within a living organism. However, the in-vitro approach
suffers from major drawbacks such as (i) the process is not reliable- typically most of
the candidate drugs that are considered to be effective through in-vitro process prove
to be ineffective in in-vivo process due to the toxicity issues occurred in the essentials
parts of the organism that were missed during the in-vitro studies and also other issues
caused with the delivery of drug to the affected tissues. (ii) It is experimentally very
difficult to perform an actual protein binding event in a complex cellular environment
with many ligands that could have caused the biological binding affinity phenomenon
with the target protein and iii) they require a substantial investment both in time and
monetary resources, to establish a large-scale screening of chemical libraries of synthetic
small molecules and achieve massive throughput abilities, which is realizable only for

9

the well-equipped industrial laboratories. An alternative solution to the expensive
in-vitro and in-vivo screening approaches is to perform an in-silico or virtual screening
(simulation-based) of small chemicals against biological protein targets. [11] [13] [14].
Virtual screening is a computational approach that increases the rate of discovery
while reducing the need for expensive pre-clinical lab trials. The idea is that it searches
for libraries of small molecules and later identifies those which can successfully bind to
the target protein followed by applying a scoring function to estimate the likelihood
that the ligand will bind to the protein with high affinity [15].
The most fundamental goal in drug design is to predict how strongly a given
molecule binds to the target protein. Structure-based drug design gives knowledge of
the structure of a protein-target, to identify potential drug candidates that possess the
desired chemical, structural properties needed to bind to the target protein. The most
frequent technique used to estimate the strength of the intermolecular interaction
between the ligand and the protein is described by molecular dynamics (MD). MD is a
structure-based drug design tool that is used to predict the conformations of the ligand
and the changes occurred in the functionality of the protein when the ligand binds to
it. In this computational simulation approach, the 3-dimensional structures of both
protein targets and potential ligands, as well as their physical and chemical properties,
are modelled to perform a ”docking” process. Various structure-based drug design tools
such as molecular dynamics (MD) simulations based on Monte-Carlo or Markov-State
models are often employed for protein-ligand docking [16]. The molecular docking
process results in large number of potential ligand orientations among which some can
be immediately rejected due to a mismatch with the target protein and the rest could
10

be evaluated using a scoring function, which takes a potential ligand orientation as an
input and returns a number indicating the likelihood and use the predicted affinity
of likelihood as a criterion for selection [17]. Hence, protein-ligand docking can be
surmised as a modelling technique that predicts the orientation of a potential drug
candidate that has a high likelihood of success during clinical trials. However, the use
of MD simulations to emulate the protein-ligand docking process has its own share
of challenges to include the prerequisite need for domain-specific knowledge of the
structure of both the target protein and ligands [16].

2.1.3

Summary
Although MD simulations serve as an excellent basis for validation and proof-of

concept of docking process, when presented with a new protein target that has no
prior repository of known ligands (i.e. no prior information), the likelihood that a
particular protein conformation will be selected over other conformations is not known.
This is often a challenging task comparatively, in having prior information of the
drug candidates that can potentially bind with the target protein. There are cases
in the drug discovery process where we will be given new molecular conformations
for which the binding is not known, and we want to determine the conformations
that can potentially bind with the target protein or not. Thus, MD simulations do
not provide data-driven insights into the identification of data-patterns such as the
bio-physical or chemical properties of ligand at-large that enables the selection of
specific target protein conformations over the others. These problems highlight the
need for advanced ML techniques that can analytically determine a precise binding
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with the least amount of time, cost expended with minimal pre-clinical lab trials and
reduced failure rates at much early-stages in the drug discovery pipeline.

2.2

2.2.1

Machine Learning Techniques used in this work

Class Imbalance Problem
Most of the real-world biomedical datasets suffer from statistical ill-conditioning

issues such as class imbalance problem, where majority of the data belongs to one
class and the rest belongs to the other class. Ideally, the key to achieve a good
classification performance is to have a well-balanced training dataset, which consists
of equally-represented population of different classes or groups of data. Whereas, in
real-world drug discovery applications, the datasets observed have population disparity,
where the majority class of non-drug candidate protein conformations dominates the
fewer class of potential drug candidate conformations. This form of unequal statistical
distribution of multi-class samples is termed as between-class imbalance problem. In
such cases, the training phase of any supervised classifier constitutes data-learning
performed on unequal distribution of representative samples from the imbalanced
dataset, wherein the classifier aims to achieve a good classification/prediction performance
without any consideration for the data distribution of each class. Hence, the resultant
decision-making process tends to be more biased towards the majority class, thereby
leading to the misclassification of minority class samples [18]. In such situations, where
we want to detect instances of a minority class, we are usually concerned more with
recall than precision during the prediction, and usually it is more costly to misclassify
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a potential drug candidate conformation than to falsely label a non-drug candidate
conformation. Conventional ML algorithms are not directly equipped to handle the
class imbalance problem as they assume that the dataset is well-balanced during the
training/data-learning phase and that the cost obtained for all the classes is same [19].
This is because most of the ML algorithms are designed to maximize the accuracy and
reduce the error. Therefore, in the prediction phase, they are more biased towards the
class that has majority of instances/representative samples thereby misclassify large
number of minority samples. Thus, the penalty cost of misclassification of minority
samples is higher than the majority samples for a class imbalance problem [20].
In drug discovery application, the class imbalance problem is of great consequence,
since it leads to a higher risk of discarding the smaller population of molecular
conformations that can successfully bind to the target proteins due to them being
misclassified as non-drug candidate conformations. At the same time, on misclassifying
non-drug candidate conformations as potential drug candidate conformations and
recommending them to the clinicians for in-vitro analysis, will lead to a substantial
increase in the investment of resources. Therefore, to overcome this issue and achieve
an optimized ML prediction performance of drug candidate conformations a good
sampling technique must be proposed to reinforce the preferred well-balanced nature
of datasets.
A similar research work was carried out in the field of drug discovery where
the goal was to predict the drug-target interaction by handling within class and
between class imbalance problem via ensemble learning [21]. Here the authors have
performed oversampling technique based on K-Means++ clustering method to solve
13

the within class imbalance problem and randomly undersampled the data instances of
majority class to solve the between class problem. The authors had handled the class
imbalance problem by oversampling the minority class while discarding large amount of
information from majority class. The main difference between our approach and other
alternative approaches is, in our work we are partially handling the class imbalance
problem in a new perspective in order to maximize the detection of both potential
drug candidate conformations and non-drug candidate conformations by proposing the
two-stage sampling-based classifier system. The main idea behind proposing such a
system is to maximize the detection of potential drug candidate conformations as they
are less in proportion compared to non-drug candidate conformations in real-world
datasets. At the same time, it is highly important to maximize the detection of
non-drug candidate conformations to achieve a substantial reduction in the investment
of resources such as time, cost and excessive lab trials during the in-vitro analysis.
Chapter 3 and 4 discusses in-detail about the proposed method and the design of the
two-stage sampling-based classifier system.

2.2.2

Sampling Strategies
The two broad categories of sampling strategies are undersampling approach

and oversampling approach.
• Undersampling: Here sampling is performed by removal of additional data
instances from the majority class samples in the training phase.
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• Oversampling: Here sampling is performed by addition of artificial data instances
to the minority class samples [21] in the training phase.
Thus, using oversampling approach the number of minority class samples increase and
on using undersampling approach the number of majority class samples reduce to
balance the class distribution in the training phase.
One of the most popular techniques for performing undersampling is a random
undersampling approach, which selects N samples at random from the majority
class and adds them to the new smaller training set (with same N total number of
samples) that consists of equal distribution of minority class data. The main drawback
of undersampling approach is that it entails a substantial risk of loss of important
information due to elimination of large number of original data samples from the
training phase [20], [22] [23]. In order to handle the issue of potential information loss
an undersampling approach, “nearest neighbor” method and its variations had been
proposed. The basic algorithms of the nearest neighbor family calculates the distances
between all the instances of the majority class and the instances of the minority class
and later selects K instances of the majority class that have the smallest distances to
those in the minority class [24].
In contrast, the oversampling approach generates artificial data samples of
the minority class and adds them to the new training dataset to obtain the desired
well-balanced data which consists of equal distribution of majority and minority class
data samples [19]. The advantage of this sampling strategy is that, there is no loss of
information involved since all the original data samples are retained in the training
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phase. Random oversampling approach is the most preferred oversampling technique
where, it selects the minority class data samples at random from the training dataset
and replicates them to create equal distribution of minority data samples [19]. The
problem with this technique is its inherent data redundant nature due to replication
of minority class samples which leads to overfitting problems during the data-learning
phase.
An alternate solution is the use of synthetic minority oversampling technique
(SMOTE) proposed by Chawla [25], where it creates new synthetic data samples of
the minority class and adds them to the new training data set, thus reducing the
overfitting problem that arises due to data replication. For this, SMOTE identifies k
nearest neighbors for each data sample belonging to minority class and then performs
regression to fit the data samples to a line in order to generate the new synthetic data
samples for the minority class [25]. The only problem with oversampling approach is
that for larger datasets the increase in training data size also implies a corresponding
increase in time-complexity of the data-learning phase.

2.2.3

Logistic Regression
Logistic regression (LR) is one of the popular ML techniques that is used to

perform predictive analysis of data, when the data is categorical or has binary classes.
It analyzes the relationship between multiple independent variables and a categorical
dependent variable, thereby it estimates the probability of occurrence of an event by
fitting the data to a logistic curve. LR has two kinds of models, they are binary logistic
regression and multinomial logistic regression. Binary logistic regression is typically
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used when the dependent variable has only 2 levels, and the independent variables are
either continuous or categorical. Multinomial logistic regression on the other hand, is
used when the dependent variable is comprised of more than two levels [26]. The goal
of LR is to determine the best fitting model that describes the relationship between
one dependent binary variable against a group of independent variables [27]. LR
models the transformed probability as a linear relationship of independent variables.
Let y be the binary outcome indicating failure/success (not belong to the class/belongs
to the class) with 0/1 respectively and p be the probability of y = 1 as p=prob(y=1).
Conversely, y = 0 can be expressed as 1 − p. Then LR models the outcome y based on
linear combination of the independent data variables x1 , x2 , ..., xk and their respective
parameter/weight values β 1 ,β 2 ,...,β k via maximum likelihood method is given by:

f (p) = log

p
= β0 + β1 x1 + β2 x2 + β3 x3 + ... + βk xk
p−1

(2.1)

When the response is a binary variable and x is continuous, logistic regression
fits a logistic curve to the relationship between x and y. Logistic curve is an S-shaped or
sigmoid curve. A logistic curve starts with slow, linear growth, followed by exponential
growth, which then slows again to a stable rate as shown in an example Figure 2.1. A
simple logistic function is given as,

y=

ex
1
=
x
1+e
1 + e−x
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(2.2)

Figure 2.1: Graph of sigmoid curve

For an accurate LR model with minimum error, we determine the cost function
J(θ) such that the square error between the actual values of y and its predicted
values ŷ is minimized. Thus, using mean squared error formulation for LR makes the
cost function J(θ) non-convex with multiple local minima. Therefore, we use cross
entropy-based LR formulation, where cross entropy H is defined as the dissimilarity
measure between the probability p corresponding to actual values y and predicted
probability p̂ corresponding to the predicted values ŷ can be calculated as:

H(p, p̂) = −

X

pi log p̂

i

(2.3)

= −y log ŷ − (1 − y) log(1 − ŷ)
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From equation 2.3 above, the new cross entropy-based LR cost function can be
formulated as:
J(θ) = −

N
1 X
H(p, p̂)
N n=1

N

1 X
=−
y log ŷ + (1 − y) log(1 − ŷ)
N n=1

2.2.4

(2.4)

Gaussian Naı̈ve Bayes Classifier
Gaussian Naive Bayes (GB) classifier is another commonly used ML supervised

technique for data classification purposes based on Bayes theory. It follows the principle
of maximum a posteriori probability (MAP) estimation for a probabilistic classification
of data. The posterior class probability of a test data instance is calculated using class
conditional density estimation and class prior probability parameters and is assigned
to the class with the maximum posterior class probability [28].
Given y ∈ {0, 1} as the binary class outcome to assign a new data point x.
According to Bayes theorem, the posterior probability P (y|x) can be expressed in
terms of prior probability P (y) and likelihood P (x|y) as described by:

P (y|x) = (P (x|y) ∗ P (y))/P (x)

(2.5)

where, P (x) is the average probability of data over all classes.
• P (y|x) is the probability of outcome y given the data point x. This is called the
posterior probability.
• P (x|y) is the probability of data point x given that the outcome y was true.
This is called the likelihood.
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• P (y) is the probability of outcome y being true across all of the data. This is
called the prior probability of y.
• P (x) is the probability of the data averaged over all of the outcomes.
Therefore, the posterior probability for different outcomes or classes is calculated
from equation 2.5 and the outcome with the highest probability obtained for classifying
the new data point x. This strategy is called the MAP estimation as formulated
below:
max(P (y|x)) = max((P (x|y) ∗ P (y)))

(2.6)

Gaussian Naive Bayes (GB) classifier is used when the features have continuous
values and follow Gaussian or normal distribution [29]. The likelihood of the features
is assumed to be Gaussian and is given by,

1
−(x − µy )2 
P (x|y) = p
exp
2σy2
2πσy2

(2.7)

where µy denotes the mean of class y and σy2 gives the variance of class y. The standard
normal distribution N (µ, σ) is a bell shaped density described by its mean µ = 0 and
standard deviation σ = 1.

2.2.5

K-Nearest Neighbors
K-nearest neighbor (KNN) classifier is a widely used ML technique for its

easy interpretation, simplicity and effectiveness for both classification and regression
problems. It is a very popular classification algorithm demonstrating good performance

20

characteristics and a short period of training time. In KNN classification algorithm,
it is necessary to calculate the similarity between the sample to be classified and all
the other samples in the training dataset to obtain its K nearest samples. KNN has
few shortcomings affecting its accuracy of classification that include large memory
requirements and is prone to be affected by the imbalanced data problem. [30] [31] [32].
Given a new data point x which has to be assigned to one of the classes y ∈ {0, 1}.
KNN algorithm performs the classification task as described by the following steps [33]:
• Choose the K neighbors.
• Calculate the K nearest neighbors yi of the new data point x: D(x, yi ) =
p
(x − yi )2 where Euclidean distance is used as a metric to determine the
“nearness” or “closeness” criteria.
• Choose the K nearest neighbors of x in accordance to the minimum Euclidean
distance between x and its K closest neighbors as defined by min D(x, yi ).
• Among these chosen K neighbors, count the number of data points in each
category of class.
• Assign the new data point x to the category where the neighborhood count is
maximum.

2.2.6

Synthetic Minority Oversampling Technique Algorithm
The Synthetic Minority Oversampling Technique is a standard framework

of learning from imbalance data due to its simplicity and robustness when applied
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to different problems. SMOTE has also inspired several proposed methods to deal
with the class imbalance issue and has also contributed to new supervised learning
paradigms, such as multi-label classification and semi-supervised learning [34]. The
SMOTE Algorithm is detailed in the steps below [35] [25] [36]:
• Choose K neighbors.
• The minority class is oversampled by taking the difference between each minority
class sample (feature vector) and its K nearest neighbors.
• Multiply this difference by a random weight between 0 and 1 and add it to the
feature vector. This causes the selection of a random point along the line-of-fit
model between the two specific features.
• Thus, the synthetic data points of minority class samples are created for the
desired well-balanced dataset.
The number of synthetic data points (N ewPi ) added to the original training
dataset set is given by

N ewPi = T otal number of instances − Ni − Pi

where, Ni is the number of instances belonging to majority class and Pi is the number
of instances beloning to minority class.
The only problem on using SMOTE technique is that the training size increases
in order to have a balanced dataset due to which, the training time increases. This
problem was handled in our proposed method where the size of new training dataset
22

is maintained same as the size of original training dataset. Hence, there is no net
increase in the data-learning time.

2.2.7

K-Means Clustering
K-Means clustering is one of the simplest and popular unsupervised machine

learning algorithms because of its ease and simplicity of implementation, scalability,
speed of convergence and adaptability to sparse data [37]. Typically, unsupervised
algorithms are used to infer the data patterns of the input dataset without referring
to labelled outcomes. Cluster analysis/clustering is one of the most utilized data
mining techniques used in unsupervised learning method. The main idea behind
cluster analysis is to understand the data patterns of the input data by grouping
the data instances that are similar to each other into one cluster and data instances
that are different from each other into different clusters. The primary goal for any
clustering algorithm is to produce well compact clusters with maximum inter-cluster
distances and minimum intra-cluster distances [37]. The quality of cluster analysis
outcome depends on the algorithm, distance function and application.
The main objective of K-Means algorithm is to group similar data instances
together to obtain compact well separated clusters and discover underlying data
patterns within them. To achieve this objective, K-Means partitions the data into a
fixed user-specified number of clusters K , where K refers to the number of clusters [38].
Each cluster is represented by a single point, known as the centroid of the cluster.
Therefore, for K clusters we will have K centroids. The centroid of ith cluster is
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computed as the mean of all data points in a cluster and is given as,

ci =

N
X

xk

(2.8)

k=1

where N represent number of datapoints with in the cluster and i goes from 1,2,....K
Traditional K-Means Clustering Algorithm:
• Initialize K as the number of clusters to be determined.
• The initial estimates for the K centroids are randomly selected from the dataset.
• Each data point is assigned to its nearest centroid based on the squared Euclidean
distance measure.
Let us consider ci as the collection of centroids in set C, then each data point x
is assigned to a cluster based on

min{dist(ci , x)2 }

Let the set of data points assigned to each ith cluster be Si
• Update the cluster centers/centroids ci as the mean of all the data points assigned
to that centroid’s cluster where ci is given as:

ci =

1 X
xi
Si
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• The algorithm iterates between step 3 and 4 until convergence i.e if the cluster
centers remain unchanged stop else go to step 3 and 4.
Choosing the optimal value of K / number of clusters:
Choosing the optimal number of clusters is an essential task in K-Means clustering
algorithm. One of the widely used methods to validate the number of clusters is the
elbow method.
The idea behind elbow method is to run the K-Means clustering algorithm on
the dataset for an extensive range of values K , where the maximum value of K is
the number of datapoints in the dataset, and for each value of K, calculate the total
within-cluster sum of squares (WCSS).
WCSS is a measure of the variability of the observations within each cluster. It
is the mean distance between the datapoints and their cluster centroid and is given as,

W CSS =

X
Pi in Cluster1

(Pi , C1 )2 +

X

(Pi , C2 )2 + ......... +

Pi in Cluster2

X

(Pi , Ck )2

Pi in ClusterK

(2.9)
where, Pi represents the set of datapoints within the dataset and the summation
represents the sum of distance of every datapoint to the centroid of cluster.
Now plot the values of total WCSS for each value of K (number of clusters). The line
chart obtained looks like an arm, then the elbow on the arm is the value of K that
gives the desired number of clusters. The total WCSS measures the compactness of
the clustering, this implies that the cluster that has less WCSS is more compact than
a cluster that has a high WCSS. The value of WCSS decreases as K increases and
W CSS=0 when K=number of datapoints in the dataset because at this point, there
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Figure 2.2: Visualization of Elbow method

is no error between the datapoints as each datapoint can be viewed as a cluster of its
own. So, our goal is to find the small value of K that has less WCSS and the elbow
represents the starting point of diminishing returns on increase of K. [39] [40]. From
the example Figure 2.2, we can see that the optimal number of clusters chosen is 4
as there is a huge drop of WCSS and later there is just a slight decrease. Cluster
Validity Indices:
Cluster validity indices are used to determine the confidence in the chosen K clusters.
They play an essential role in determining the cluster quality. The cluster quality
is good when the datapoints are close to each other within the cluster and far from
each other between the clusters. Thus, the confidence measures the compactness
of the clusters. However, in some cases, when elbow method doesn’t perform well
in determining right number of clusters then the cluster validity indices are used

26

to determine the right number of clusters present in the data. There are different
methods used to measure the cluster quality, some of them used in this research work
are [40]:
Davies-Bouldin Index: It evaluates intra-cluster similarity and inter-cluster
differences. It is defined, as a function of the ratio of the within cluster scatter, to the
between cluster separation, a lower value means that a better separation between the
clusters.
Silhouette Index: The Silhouette Coefficient is calculated using the mean
intra-cluster distance (a) and the mean nearest-cluster distance (b) for each sample.
The Silhouette Coefficient for a sample is (b - a) / max (a, b). Higher Silhouette
Coefficient score relates to a model with better defined clusters.
We have chosen DB Index and Silhouette index for this work because they
are well suitable for the problem as they use only the internal information of the
clustering process to evaluate the goodness of a clustering structure without reference
to external information such as comparing the obtained cluster labels to externally
provided class labels. Such a process is termed as internal cluster validation.

2.2.8

Feature Selection Techniques
When the number of features is very large, most traditional algorithms struggle

to train effective models as the amount of data required to generalize accurately grows
exponentially. This phenomenon is called as “Curse of dimensionality”. Therefore, to
tackle the curse of dimensionality, high storage and other computational problems,
dimensionality reduction (DR) techniques are often adopted. The goal of DR techniques
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is to project a high dimensional data into its low dimensional subspace based on an
objective function such that the important information is preserved. DR techniques
subdivide into feature extraction techniques and feature selection techniques.
Feature extraction can be defined as the process of creating new smaller set
of features such that maximum amount of information in data is preserved, whereas
feature selection can be defined as the process of selecting a subset of relevant features
from a set of original features in the training phase of data such that the important
information in data is preserved. The main difference between both the techniques is
that feature selection retains a subset of original features, while feature extraction
creates new ones by projecting the data in a direction which is dictated by some
objective function or mathematical criteria such as direction of maximum variance or
minimum error.
Overall, it is very important to understand which features/dimensions provide
relevant information about the data for enhanced classification performance as well as
to facilitate reduction in computational time required to learn the relevant patterns in
the data. Relevant features could be defined as those features that contribute most
in determining the dependent variable compared to other features. [41]. The main
idea behind using feature selection techniques is to remove data whose features are
redundant or irrelevant such that only important information in the data is preserved.
These selected features are then expected to contain the relevant information from
the input data, so that the desired task can be performed by using this reduced
representation instead of complete original data and achieve approximately same
amount of accuracy. Some of the advantages of using feature selections techniques are:
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• It enables the ML algorithms to train faster for larger datasets.
• It reduces overfitting and complexity of a model.
• If improves the accuracy of a model if the right subset of features is chosen.
The motivation behind performing feature selection techniques in our research work is
to understand the features that contribute more information in terms of determining
the binding state of the protein conformations.

Feature selection techniques:
Basically, there are 3 different methods to perform feature selection. They are as
follows:
1) Wrapper methods: These methods are used to measure the “usefulness”
of features based on the classifier performance. Some examples of these methods
include recursive feature elimination, sequential feature selection algorithms. Here,
we use a subset of features and train a ML model using the selected features. Based
on the outcomes we decide to add or remove the features from the subset. These
methods are computationally expensive as they undergo repeated learning steps and
cross-validation.
2) Filter methods: These methods choose the intrinsic properties of the features
i.e. they measure the relevance of the features with respect to the target variable using
univariate feature selection. Univariate feature selection uses statistical tests such as
Analysis of variance (ANOVA) F-test, mutual information (MI), Chi-Square test to
assess the relationship between each input feature and the output target variable.
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3) Embedded methods: These methods are used to optimize the objective
function or performance of learning model and they are similar to wrapper methods.
The difference between wrapper methods and embedded methods is that embedded
methods use an intrinsic model building metric during the learning phase. Example:
decision trees, regularization techniques.

In particular, the feature selection techniques used in this work are:
Analysis of variance F-test (ANOVA F-test): It is a statistical method to
calculate the linear dependency between each feature and the target variable and
select the features with the highest F scores. F score is the variance calculated by
taking the sum of squares between groups divided by sum of squares within the group
where sum of squares between groups implies the variation due to interaction between
the samples and sum of squares within groups implies the variation due to differences
within individual samples. The F value in the ANOVA test also determines the p-value
where p-value is defined as the probability of getting a result at least as extreme
as the one that was actually observed, given that the null hypothesis is true. The
higher the F-value, the more the feature is important. Hence after performing this
test, all the features are removed except the one’s having the highest scores. Since the
data features in this work were quantitative and the response variable is categorical,
ANOVA-F test was therefore employed to perform feature selection. In this work, we
perform ANOVA between each feature and target vector and the obtained F-value is
assigned to that feature. Later, the features are ranked based on the F-values and top

30

K features are retained where K is defined by user.

Mutual Information: Mutual Information (MI) is defined as a measure
between two random variables X and Y, that determines the amount of information
obtained about one random variable, through the other random variable. In information
theory, entropy is an important basis used for measurement for information. Entropy
is defined as a measure of uncertainty present in the given data or information [42].
Let X be a random variable and p(X) is its probability density function, then
the entropy is defined as:

H(X) = −

X

p(x) log(p(x))

(2.10)

x∈X

Conditional entropy refers to the uncertainty reduction of one variable when the other
is known. Assume that variable Y is given, the conditional entropy H(X|Y ) of X with
respect to Y is
H(X|Y ) = −

XX

p(x, y) log(p(x|y))

(2.11)

y∈Y x∈X

where p(x, y) is the joint probability density function and p(x|y) is the posterior
probabilities of X given Y.
From equation 2.10 and 2.11, mutual information I(X;Y) can be defined as,
I(X;Y) [42] below:

I(X; Y ) = H(X) − H(X|Y ) = −

XX
y∈Y x∈X
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p(x, y) log

p(x, y)
p(x) p(y)

(2.12)

From equation 2.12, if X and Y are independent of each other i.e. unrelated, their MI
=0. Similarly, if X and Y are dependent on each other their MI=1. Here, independent
implies, no information of Y can be obtained using X. Similarly, dependent implies,
we can determine X from Y or vice-versa.
MI can also be utilized as a feature selection technique as it provides a measure to
quantify the relevance of a feature subset with respect to the target variable [43]. It
can be estimated as follows:
• Initially the MI which measures the dependency between feature vector and the
target variable is computed for every feature.
• The features are then ranked based on their MI values.
• Select our K top features from the list, where K is defined by the user.
Extra Trees Classifier as feature selection: Embedded methods can be used as
feature selection techniques as:
• They are highly accurate
• Easily interpretable
• They generalize better
Among the ensemble methods, Extra trees classifier is generally cheaper to
train from a computational point of view and hence we have chosen Extra Trees
classifier for this research work. In this technique, the importance of each feature is
calculated during training phase based on information gain. Information gain measures
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how much information a features gives us about the class label. Features with high
information gain are considered to be important in determining the dependent variable.
Features that are selected at the top of the tree are generally more important than
the features that are selected at the end nodes. Selecting features by using extra
tree-derived feature selection technique is a very straight forward, fast and generally
accurate way of selecting good features for ML model.

2.3

Summary

In this chapter we have discussed about drug discovery and it’s implications in
modern healthcare. We have also elaborated on the theoretical concepts of various
supervised, unsupervised learning techniques and different types of feature selection
techniques used in this research work. In Chapter 3 and 4 we will further discuss the
methodology behind designing our drug discovery system using our proposed method
two-stage sampling-based classifier system.
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CHAPTER 3

PROPOSED METHODOLOGIES

We have proposed a drug detection system - two-stage sampling-based classifier
system to maximize the detection of both potential drug candidate- and non-drug
candidate conformations. For classification purposes, we denote the non-drug molecular
conformation samples that have inactive binding to target proteins as belonging to
class 0 and potential drug candidate molecular conformations that have active binding
to target proteins as class 1 samples. Thus, this is a binary classification problem
and we use this as a basis to design a comprehensive drug-candidate conformation
detection system that leverages the detection of both potential drug-candidate and
non-drug candidate conformations for expedited clinical trials.
Among several classifiers applied to the training phase of the dataset, it was experimentally
found that Logistic Regression (LR) had excellent classification performance in
detection of maximum non-drug conformations and Gaussian Naive Bayes (GB)
classifier provided better detection of potential binding drug candidate conformations
compared to other classifiers. Also, we have chosen KNN classifier as a second expert
for our proposed method as it showed a decent detection of potential binding drug
candidate conformations. The choice of classifiers chosen for this research work are
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further discussed in detail under Section 3.4. The proposed drug detection system
comprises of two stages:
• First stage consists of our Methodology 1 classifier which is responsible for
maximizing the detection of non-drug conformations (class 0 samples) using LR
classifier.
• Second stage comprises of our Methodology 2 classification system using GB
classifier and KNN classifier, which are responsible for maximizing the detection
of potential binding drug candidate conformations /class 1 samples.

3.0.1

Two-Stage Sampling-Based Classifier Algorithm

• First, the Methodology 1 classifier is applied to our original training data which
inherently has a biased population that consists of a large number of inactive
binding non-drug conformations/class 0 samples. Both the identified class 0 and
class 1 samples are recorded as Methodology 1 results.
• A new training dataset is obtained by performing random undersampling of class
0 samples and oversampling of desired class 1 samples using SMOTE algorithm
to tackle with class-imbalance problem and maximize the detection rate of active
binding drug candidate conformations/class 1 samples. For consistency the size
of new training dataset is maintained same as the size of original training dataset.
Hence, there is no increase in the data-learning time.
On using random undersampling, there will be a significant loss of information
in data samples belonging to class 0. This issue has been handled as we have
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proposed a novel technique of undersampling based on K-Means clustering
method that will be discussed in Chapter 4.
• Methodology 2 classification system is then applied to our new training dataset
which is biased with class 1 samples. We denote the corresponding technique
of re-balanced dataset using SMOTE followed by Methodology 2 classification
system as SMOTE-GB and SMOTE-KNN techniques. This step of Methodology
2 classification is performed to reaffirm the active binding and inactive binding
molecular conformations that are identified by Methodology 1 classifier for a
more robust drug-candidate conformation detection system. Since Methodology
2 classifier has greater affinity towards detection of potential active binding
drug-candidate conformations, the new unique class 1 samples identified are
recorded in Methodology 2 results.
• Finally, a decision fusion strategy via majority voting is implemented to uniquely
identify the total number of potential active binding drug candidate and inactive
binding non-drug molecular conformations acquired from Methodology 1 and
Methodology 2 classification models. The corresponding decision fusion strategies
are denoted by LR+SMOTE-GB and LR+SMOTE-KNN techniques. Figure 3.1
depicts the flowchart of the proposed two-stage tailored sampling-based drug
conformation classification system.
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3.1

Motivation

The motivation behind using a Methodology 1 classifier is to identify the
maximum number of non-drug protein conformations, whereas the Methodology 2
classifier is used to provide an additional layer of security to reconfirm the potential-drug
conformations identified by the Methodology 1 classifier along with the identification
of new potential-drug conformations through decision fusion strategy. This form
of two-stage tailored binary classification system ensures maximum detection of
both potential drug candidate- and non-drug protein conformations at each step,
consequently, it aims to reduce the failure rates incurred during the clinical trials
involved in the drug development process. The identified protein conformations can
considered by the clinicians for informed decision-making to discard the non-drug
candidate protein conformations and consider only the potential drug-candidate protein
conformations while performing in-vitro experimental approaches thus reducing the
substantial investment of resources that include time, cost and rigorous lab testing
trials.

3.2

Datasets Description

In this work, proteins ADORA2A (Adenosine A2a Receptor) and OPRK1
(Opioid Receptor Kappa 1) are considered to perform the experimental evaluation of
the proposed methods.
ADORA2A: This gene encodes a member of the guanine nucleotide-binding protein
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Figure 3.1: Flowchart of the proposed Two-stage sampling-based classifier.

(G protein)-coupled receptor (GPCR) superfamily, which is subdivided into classes
and subtypes [44] . The given dataset consists of 50 attributes with 3000 molecular
conformations among which 850 conformations have the potential to bind with the
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protein and 2147 conformations don’t bind with the protein. Here the imbalance ratio
is 3:1 i.e. for every datasample belonging to minority class there are 3 data samples
belonging to majority class
OPRK1: This gene encodes an opioid receptor, and is a member of the 7 transmembrane
spanning G protein-coupled receptor family. This is a protein coding gene. The given
dataset consists of 50 attributes with 2999 molecular conformations among which 137
conformations have the potential to bind with the protein and 2862 conformations
don’t bind with the protein. Here, the imbalance ratio is 20:1 i.e. for every datasample
belonging to minority class there are 20 datasamples belonging to majority class.
The goal is to identify maximum number of molecular conformations related
to the ADORA2A and OPRK1 proteins and recommend the identified smaller subset
for more efficient pre-clinical lab trials. The datasets have an active binding feature
as the “dependent variable” which has 2 classes labeled as either 0 or 1 to indicate
the binding outcome. Class 0 describes that the given molecular conformation does
not successfully bind to the target protein and class 1 conveys that the molecular
conformation successfully binds to the target protein.
In this research work we have conducted 2 different experiments using the
proposed drug discovery system and they are defined as below:
• Experiment 1: Supervised Learning - In this case we study the effects of class
imbalance problem on classification performance. For this, we have trained the
dataset using our proposed model and evaluated the total detection rates of
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molecular conformations available in the test phase. This experiment has been
further categorized into 2 different cases:
– Case1: Supervised Learning using Random Undersampling-SMOTE technique.
– Case2: Supervised Learning using K-Means clustering-based undersampling
technique.
• Experiment 2: Supervised Learning with Feature selection- In this case we had
explored different feature selections techniques on the datasets to understand the
contribution and the importance of each feature with respect to the target variable
in order to determine the properties that play a vital role in defining the protein
constitution. Also, we have analyzed the protein datasets by implementing
the proposed pipeline using the selected subset of features and evaluated its
classification performance.

3.3

Performance Evaluation

We have explored 7 supervised ML classification models in order to evaluate
the performance of the defined experiments in Section 3.2. They are:
• Methodology 1 classification using LR classifier
• Methodology 2 classification using GB and KNN classifiers
• Creating a new training dataset using SMOTE and undersampling techniques
followed by Methodology 2 classification techniques: SMOTE-GB, and SMOTE-KNN
• Decision fusion using LR+SMOTE-GB and LR+SMOTE-KNN techniques
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The experimental validation was conducted on 10% , 20% and 30% of training
data sizes for supervised learning, where the training samples were randomly chosen
from the original dataset. This training set range was chosen because in reality there
are only a smaller number of conformations available for data-learning and training
the supervised classifier. In the context of protein conformational selection for drug
discovery application, a confusion matrix presents the summary of prediction/classification
results of a given protein conformation as belonging to one of the below four cases:
• True positives (TP): The cases for which the classifier predicted “Active Binding”
(drug candidate) and the conformations were actually bounded to the target
protein. They are correct detection cases where the predicted drug candidate
conformations were indeed true drug candidates (class1 samples).
• True negatives (TN): The cases for which the classifier predicted “Inactive Binding”
(non-drug candidate) and the conformations were actually not bounded to
the target protein. They represent correct detection cases were the predicted
non-drug candidate conformations were indeed true non-drug candidates (class
0 samples).
• False negatives (FN): The cases for which the classifier predicted “Inactive Binding”
(non-drug candidate) but the conformations were actually bounded to the target
protein. These constitute the drug candidate conformations (class 1 samples)
that were erroneously classified as non-drug candidates (class 0 samples).
• False positives (FP): The cases for which the classifier predicted “Active Binding”
(drug candidate) but the conformations were actually not bounded to the target
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protein. These are the non-drug candidate conformations (class 0 samples) that
were misclassified as potential drug candidates (class 1 samples).

The quantitative performance analysis of the proposed classification techniques is
conducted using measures as defined below:
Classification Accuracy (Acc): The accuracy of a test is defined as, the ability
to differentiate the “Active Binding” and “Inactive Binding” cases correctly.
Mathematically, it is given by,

Classif ication Accuracy =

TP + TN
× 100
N

where,
N = TP + TN + FP + FN

Sensitivity (Se): The sensitivity of a test is defined as, the ability to determine
the “Active Binding” cases correctly. Mathematically, it is given by,

Sensitivity =

TP
TP + FN

Specificity (Sp): The specificity of a test is defined as, the ability to determine
the “Inactive Binding” cases correctly. Mathematically, it is given by,

Specif icity =
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TN
TN + FP

3.4

Choice of optimal classifiers

In our initial experiments, several ML classifiers such as support vector machines
(SVMs), GB, LR, and KNN classifiers were explored. Most of them yielded a good
classification performance with a high detection of non-drug conformations/TNs, but
a very low detection of drug candidate conformations/TPs. This was mainly because
of the class imbalance problem, due to which the performance of the classification
model was more biased towards the majority class; i.e. class 0 samples in this case.
This prompted us to design a system specifically to handle the classes imbalance
problem and maximize the detection of TPs, TNs and evaluate the performance of
our proposed methods through the standard classification metrics as discussed in
Section 3.3 that adequately represent the model performance.

Table 3.1: Choice of Methodology 1 and Methodology 2 classifier for ADORA2A
dataset for Training Size 70%.
Classifier
SVM
KNN
Random Forest
LR
Adaboost
GB

TP
0
58
26
41
48
121

TN
647
542
614
594
567
448

FN
253
195
227
212
205
132

FP
0
105
33
53
80
199

Acc
71.88
66.6
71.11
70.5
68.33
63.2

From Table 3.1 and Table 3.2 we can observe that Gaussian Naive Bayes(GB)
classifier has excelled in determining high number of T P of 121 and 279 for training
sizes 70% and 30% compared to other classifiers. The class imbalance problem is
clearly evident in the case of SVM classifier where it detects the entire population
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Table 3.2: Choice of Methodology 1 and Methodology 2 classifier for ADORA2A
dataset for Training Size 30%.
Classifier
SVM
KNN
Random Forest
LR
Adaboost
GB

TP
0
149
80
143
149
279

TN
1519
1245
1383
1320
1262
1059

FN
579
430
499
436
430
300

FP
0
274
136
199
257
460

Acc
72.4
66.4
69.7
69.7
67.2
63.7

of class 0 samples and none from class 1 samples. Comparatively, Random Forest
has the second highest detection of T N but has detected only 26 and 80 T P for the
training sizes 70% and 30% respectively whereas, LR has the third highest detection
of T N and has detected a decent number of T P with values 41 and 143 for training
sizes 70% and 30%. Hence, we have chosen LR as our Methodology 1 classifier as
it has detected good number of non-drug candidate conformations and GB as our
Methodology 2 classifier because it has detected maximum number of potential drug
candidate conformations.
We have chosen KNN as our second expert for our Methodology 2 classifier
because both KNN and Adaboost had performed well in the detection of T P but
Adaboost being an ensembled method, is usually computationally expensive and
therefore it increases learning time and memory constraints to the problem. Hence,
KNN was chosen over Adaboost.
From Table 3.3 and Table 3.4, GB classifier has detected maximum number
of potential drug conformations with 19 and 51 T P s for training size 70% and 30%
respectively for the protein OPRK1. Therefore, we have chosen GB as Methodology
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Table 3.3: Choice of Methodology 1 and Methodology 2 classifier for OPRK1 dataset
for Training Size 70%.
Classifier
SVM
KNN
Random Forest
LR
Adaboost
GB

TP
0
0
0
0
0
19

TN
862
862
862
862
857
360

FN
38
38
38
38
38
19

FP
0
0
0
0
5
502

Acc
95.7
95.7
95.7
95.7
95.2
42.1

Table 3.4: Choice of Methodology 1 and Methodology 2 classifier for OPRK1 dataset
for Training Size 30%.
Classifier
SVM
KNN
Random Forest
LR
Adaboost
GB

TP
0
0
0
0
1
51

TN
2004
2004
2004
2001
1984
804

FN
96
96
96
96
95
45

FP
0
0
0
3
20
1200

Acc
95.4
95.4
95.4
95.2
94.5
40.7

2 classifier. All the other classifiers have shown the class imbalance effect and the
results are biased towards the majority class i.e. class 0 samples and hence we have
continued with the LR as our Methodology 1 classifier and KNN as the second expert
for our Methodology 2 classification.
We have also improved the performance of LR classifier by tuning the hyperparameters
and empirically chosen the value of margin, C = 5.
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3.5

Supervised Learning on ADORA2A and OPRK1 datasets using the
proposed methodology

This section comprises of 3 test cases, namely:
• Case 1: Training set with biased population of class 0 samples - This case studies
the class imbalance effects on our original data for various training sizes. The
goal here is to maximize the TN detection by our Methodology 1 classifier and
record the corresponding results.
• Case 2: Training set with biased population of class 1 samples - This case
studies the effects of induced class imbalance on the prediction rates of molecular
conformations. The goal here is to maximize the detection of TPs identified by
our Methodology 2 classifier via using the two-stage sampling-based approach
in order to improve the model performance. For this, we perform SMOTE
oversampling of class 1 samples and undersampling of class 0 samples, such
that the new training data size is consistent with the original training data size.
Methodology 2 classifier is then employed for data-learning on the resultant new
training set.
• Case 3: Decision Fusion - This case explores a decision fusion strategy via
majority voting scheme as a means to assimilate the classification conclusions
from the Methodology 1 classifier -LR with the results from Methodology 2
classifier system: SMOTE-GB and SMOTE-KNN techniques, to arrive at a
global consensus of overall identified protein conformations that posses active
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binding property. The quantitative performance of proposed decision fusion
method is determined in terms of the below measures:

T otal accuracy =

T N1 + T P1 + N ew T N2 + N ew T P2
Ntest

where Ntest represents the total number of class 1 and class 0 samples in the test
set.
T otal T P accuracy (T P acc) =

T P1 + N ew T P2
1
Ntest

1
where Ntest
represents the total number of class 1 samples in the test set.

T otal T N accuracy (T N acc) =

T N1 + N ew T N2
0
Ntest

0
represents the total number of class 0 samples in the test set.
where Ntest

3.5.1

Experiment1 - Case1: Supervised Learning using Random Undersampling
and SMOTE techniques
This section shows the computational evaluation of supervised learning of

ADORA2A and OPRK1 performed on two-stage sampling-based classifier model using
Random undersampling approach.
Computational evaluation on ADORA2A dataset:
Case 1: Training set biased population of class 0 samples: Table 3.5 gives the
per-class samples present in accordance to the various training sizes considered. From
Table 3.6, it can be noted that LR identified 151 TPs from 579 samples of class 1 and
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Table 3.5: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
202
1945
413
1734
628
1519

class 1 samples
Training Testing
97
753
186
664
271
579

1313 TNs from 1519 samples of class 0 for a training size of 30%. Thus, the observed
results across all cases validate our argument that LR has the best classification
performance for detection of TNs or non-drug conformations.

Table 3.6: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
222
188
151

Methodology
T N1 F N1 F P1
1577 531 368
1449 476 285
1313 428 206

1 - LR
Acc
66.7
68.2
69.7

Se
0.29
0.28
0.26

Sp
0.81
0.83
0.864

From Table 3.7, it can be seen that GB identified 279 TPs from 579 samples of
class 1 and 1059 TNs from 1519 samples of class 0 for a training size of 30%. Similarly,
KNN identified 149 TPs from 579 samples of class 1 and 1245 TNs from 1519 samples
of class 0 for a training size of 30%. Thus, it can be noted that overall GB had the
best classification performance as a Methodology 2 classifier with better detection
rates of TPs or potential drug candidate conformations over KNN classifier.
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Table 3.7: Classification performance of Methodology 2 Classifier- GB and KNN on
the original training dataset.
%Training
Size
10
20
30
%Training
Size
10
20
30

T P2
463
331
279

Methodology 2 Classifier - GB
T N2 F N2 F P2 Acc
Se
1185 290 760 61.08 0.614
1165 333 569 62.3
0.49
1059 300 460 63.7
0.48

Methodology
T P2 T N2 F N2
224 1578 529
188 1424 476
149 1245 430

2 Classifier F P2 Acc
367 66.7
310 67.2
274 66.4

Sp
0.6
0.67
0.69

KNN
Se
Sp
0.29 0.81
0.28 0.82
0.25 0.81

Case 2: New training set with biased population of class 1 samples
Table 3.8 gives the per-class distribution in the new training dataset. From Table 3.8
results, we observe that the size of new training dataset is same as the size of original
training dataset. For example, in the original training dataset the number of samples
in class 0 is 628 and number of samples in class 1 is 271 for training size of 30%. Now,
in the new training dataset the number of samples in class 0 is 271 and number of
samples in class 1 is 628 for the same training size.

Table 3.8: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
97
1945
186
1734
271
1519
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class 1 samples
Training Testing
202
753
413
664
628
579

Table 3.9 describes the overall improved classification performance of two-stage
classification approach and the effects of induced class imbalance of class 1 sample
population. From Table 3.9, SMOTE-GB identified 384 TPs which is more than the
279 TPs identified using the original training dataset in Table 3.7 for the training
size of 30%. In particular, SMOTE-KNN classifier had the best Methodology 2
classification performance, wherein it identified 504 TPs which is more than the 149
TPs identified using the original training dataset in Table 3.7 for the training size of
30%. The effects of induced class imbalance are evident from the boost in classification
performance of both the Methodology 2 classifiers. In particular, SMOTE-KNN
technique works on the concept of nearest neighbor algorithm and more induced
neighbors via oversampling of class 1 samples implies better statistical conclusion of
the underlying population distribution of the potential drug candidate conformations.

Table 3.9: Classification performance of SMOTE-GB and SMOTE-KNN on the new
training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
479
420
384

T P2
632
592
504

Methodology 2 T N2 F N2 F P2
1114 274 831
943
244 791
800
195 719

SMOTE-GB
Acc
Se
59.04 0.636
56.8
0.63
56.4
0.66

Sp
0.572
0.54
0.52

Methodology 2 - SMOTE-KNN
T N2 F N2 F P2 Acc
Se
504 121 1441 42.1 0.839
408
72
408 41.7 0.89
373
75
1146 41.8 0.87

Sp
0.25
0.23
0.24
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Table 3.10 describes the overall TPs and TNs reconfirmed and identified,
including the unique TPs and TNs identified by the Methodology 2 classifier. For the
training size of 30% SMOTE-GB reconfirmed on 134 TPs identified by Methodology 1
classifier apart from identifying 250 new TPs. So, in total it identified 384 TPs using
the new training dataset. SMOTE-KNN classifier reconfirmed the 140 TPs identified
by Methodology 1 aside from identifying 364 new TPs. So, in total it identified 504
TPs using the new training dataset. Thereby, Table 3.10 further demonstrates the
effectiveness of the proposed two-stage sampling-based classification approach.

Table 3.10: Reconfirmation and identification of new TP by Methodology 2 classifiersSMOTE-GB and SMOTE-KNN

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
298
84
181
1030
262
46
158
897
250
22
134
778

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
427
28
205
476
413
26
179
382
364
11
140
362

Case 3: Decision Fusion
Table 3.11- 3.12 demonstrates the overall classification performance of the
proposed decision fusion case. From Table 3.11 and Figures 3.2-3.4, it can be inferred
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Table 3.11: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
80.8
69
85.3
20
81.1
67.7
86.2
30
82.7
69.2
87.8

Table 3.12: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-KNN
Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy TP acc TN acc
10
83.5
86.1
82.5
20
86.5
90.5
85
30
87.6
88.9
87.1

that the overall classification performance of the proposed methods: LR+SMOTE-GB
and LR+SMOTE-KNN techniques were significantly superior to individual classification
performance of LR, GB and KNN classifiers as given in Table 3.6 -Table 3.7.
From Figures 3.2-3.4, in particular, LR+SMOTE-KNN had excellent classification
performance for identification of the molecular conformations for protein ADORA2A
in terms of overall classification accuracy and TP accuracy measures.
Computational evaluation on OPRK1 dataset:
Case 1: Training set biased population of class 0 samples:
Table 3.13 gives the per-class distribution in accordance to the various training sizes
considered.
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Figure 3.2: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein ADORA2A.

Figure 3.3: TP accuracies across varying training sizes for case 1, case 2 and decision
fusion for protein ADORA2A.

From Table 3.14, the observed results across all cases validate our argument
that LR has the best classification performance for detection of TNs or non-drug
conformations due to the class imbalance problem.
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Figure 3.4: TN accuracies across varying training sizes for case 1, case 2 and decision
fusion for protein ADORA2A.

Table 3.13: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
289
2573
574
2288
858
2004

class 1 samples
Training Testing
10
127
25
112
41
96

From Table 3.15, it can be seen that GB identified 51 TPs from 96 samples of
class 1 and 804 TNs from 2004 samples of class 0 for a training size of 30%. Similarly,
KNN couldn’t identify any TPs from 96 samples of class 1 but identified 100% of
TNs of class 0 samples for a training size of 30% due to the class imbalance problem.
Thus, it can be noted that overall GB had the best classification performance as a
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Table 3.14: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
3
1
0

T N1
2531
2282
2001

Methodology
F N1 F P1
124
42
111
6
96
3

1 - LR
Acc Se
93.8 0.02
95.1
0
95.2
0

Sp
0.98
0.99
0.99

Methodology 2 classifier with better detection rates of TPs or potential drug candidate
conformations over KNN classifier.

Table 3.15: Classification performance of Methodology 2 Classifier- GB and KNN
on the original training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
27
45
51

T P2
0
0
0

Methodology 2 Classifier T N2 F N2 F P2 Acc
1983 100
590 74.44
1186
67
1102 51.2
804
45
1200 40.7

GB
Se
0.21
0.4
0.5

Sp
0.77
0.51
0.4

Methodology 2 Classifier - KNN
T N2 F N2 F P2 Acc Se Sp
2573 127
0
95.2 0
1
2287 112
1
95.2 0 0.99
2004
96
0
95.4 0
1

Case 2: New training set with biased population of class 1 samples
Table 3.16 gives the per-class distribution in the new training dataset. From Table 3.16
results, we observe that the size of new training dataset is same as the size of original
training dataset.
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Table 3.16: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
10
2573
25
2288
41
2004

class 1 samples
Training Testing
289
127
574
112
858
96

From Table 3.17, SMOTE-GB identified 61 TPs and SMOTE-KNN identified
93 TPs which is more than the TPs identified using the original training dataset
in Table 3.15 for the training size of 30%. The effects of induced class imbalance
are evident from the boost in classification performance of both the Methodology 2
classifiers.

Table 3.17: Classification performance of SMOTE-GB and SMOTE-KNN on the
new training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
59
81
61

Methodology 2 - SMOTE-GB
T N2 F N2 F P2 Acc Se
1420
68
1153 54.7 0.46
498
31
1790 24.1 0.72
602
35
1402 31.5 0.63

T P2
125
109
93

Methodology
T N2 F N2
68
2
60
3
48
3
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Sp
0.55
0.21
0.3

2 - SMOTE-KNN
F P2 Acc Se
Sp
2505
7
0.98 0.02
2228
7
0.97 0.02
1956 6.7 0.96 0.02

From Table 3.18 for the training size of 30% Methodology 1 classifier couldn’t
identify any TPs, but SMOTE-GB identified 61 new TPs and SMOTE-KNN classifier
identified 93 new TPs.

Table 3.18: Reconfirmation and identification of new TP by Methodology 2 classifiersSMOTE-GB and SMOTE-KNN

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
56
13
3
1407
80
0
1
498
61
2
0
600

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
122
0
3
68
108
1
1
59
93
0
0
48

Case 3: Decision Fusion

Table 3.19: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
96.4
46.4
98.8
20
98.4
72.3
99.7
30
98.2
63.5
99.9

Table 3.19 demonstrates the overall classification performance of the proposed
decision fusion case. From Table 3.19 - Table 3.20 and Figures 3.5- 3.7, LR+SMOTE-KNN
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Table 3.20: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-KNN
Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy TP acc TN acc
10
98.3
98.4
98.3
20
99.6
97.3
99.7
30
99.7
96.8
99.8

had excellent classification performance for identification of the molecular conformations
for protein OPRK1 in terms of overall classification accuracy and TP accuracy measures.

Figure 3.5: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein OPRK1.

3.6

Summary

This chapter introduced the proposed two-stage sampling-based classifier
system, performance evaluation metrics, description of the experiments performed
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Figure 3.6: TP accuracies across varying training sizes for case 1, case 2 and decision
fusion for protein OPRK1.

Figure 3.7: TN accuracies across varying training sizes for case 1, case 2 and decision
fusion for protein OPRK1.

to study the effects of class imbalance problem and finally presents the results of
supervised Learning using random undersampling-SMOTE approach on ADORA2A
and OPRK1 datasets. The proposed two-stage sampling-based classifier system
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LR+SMOTE-GB outperformed all other methods of comparison, thereby proving the
effectiveness of our method.
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CHAPTER 4

K-MEANS CLUSTERING-BASED UNDERSAMPLING METHOD

4.1

Supervised Learning using K-Means Clustering-based Undersampling
Approach

In the previous chapter, we discussed the methodology of two-stage sampling-based
classifier system in which we had two methodologies for maximizing the detection of
both potential drug-candidate conformations and non-drug candidate conformations.
Our Methodology 1 is applied to the original dataset which is biased with class 0
samples and hence it maximizes the detection of non-drug candidate conformations.
To tackle the class imbalace problem we created a new training dataset which is biased
with class 1 samples using undersampling and oversampling techniques. Random
undersampling was performed to remove the datasamples from the majority class and
SMOTE technique was employed to add synthetic datasamples to the minority class
to make the dataset biased towards class 1 label. However, random undersampling
removes the datasamples from the majority class randomly thus there is a substantial
risk of loosing important information belonging to the majority class. Hence, we
have proposed an alternative method of undersampling to preserve the data samples
that are more important and eliminate the data samples that are less important in
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the dataset during the training phase of the model. Also, on using this approach,
the model reconfirms more number of TN than compared to random undersampling
method during Methodology 2 classification.
K-Means Clustering-based undersampling technique:
• First we retrieve the majority class data samples into a separate dataframe
and determine the optimal number of clusters using elbow method and cluster
validity indices.
• Perform K-Means clustering on the dataframe, where K = The number of
optimal number of clusters obtained in the previous step.
• Using K-Means, the data samples that are similar to each other are grouped
into clusters. A data sample that has high similarity between the centroid and
itself is likely to be more important than a sample that has low similarity. Our
goal is to remove the datapoints that are far from the centroid as they are less
important and preserve the data samples that in the proximity of centroids.
Hence, based on this concept we have calculated the distances between the
datapoints and their respective centroids within each cluster.
• To remove the datapoints that are far from the centroid we have first normalised
the distances with respect to the total number of samples within each cluster
where the normalised datapoints (DN ) within each cluster is computed as follows:

DN =
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DC
NC

(4.1)

where DC = Distance between the data point and its centroid and NC = Total
number of datapoints within the cluster.
• We then calculate the mean of datapoints within each cluster denote by m1 ,m2 ,m3 ,...mK
where K= total number of clusters/ centroids, where the mean for each cluster
is computed as follows:
mK =

SC
NC

(4.2)

where, SC is the sum of the distances of all datasamples belonging to the cluster.
• To remove the datasamples that are far from centroid a threshold parameter
needs to be chosen. This threshold value is chosen by computing the mode of
the means that we have obtained in (4.2). The reason behind choosing mode
over median is because it is suitable to our problem and we have obtained well
separated and compact clusters on using mode over median, The compactness
of the clusters on using median is shown in Figure 4.1. The threshold value is
computed a follows:

T hreshold = mode(m1 , m2 , m3 , ...mK )

(4.3)

• Finally, after computing the threshold value, the datasamples whose distance
from centroid is greater than the threshold value are considered to unimportant
and hence removed from the dataset.
From Figure 4.1 and Figure 4.5 we can infer that on using mode statistical measure
the clusters obtained are very well separated and compact in nature.
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Figure 4.1: Compactness of clusters on using proposed K-Means undersampling
technique using median

4.2

Experiment1- Case 2: Supervised Learning with K-Means undersampling
techique on ADORA2A and OPRK1 datasets.

In this section we experimentally validate the proposed two-stage K-Means
sampling-based classifier model on the original datasets ADORA2A and OPRK1 and
evaluated its performance.

4.2.1

Choice of optimal number of clusters for K-Means undersampling
technique
In this section we determine the optimal number of clusters for both ADORA2A

and OPRK1 dataset in order to further implement the proposed K-Means clustering-based
undersampling technique. For this, several cluster validity indicies are explored.
Through elbow method in Figure 4.2, we observe that there is a huge drop in WCSS
at number of clusters=3 and later on there is a slight decrease. Also, the cluster
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validity indices were calculated as shown in Table 4.1. We can observe that the number
of optimal clusters chosen are 3 as DB-Index is less and Silhouette Index is high
comparatively to other number of clusters. Hence for ADORA2A dataset K= 3 is
chosen for optimal number of clusters.

Figure 4.2: Optimal number of clusters for ADORA2A dataset using Elbow method

Table 4.1: Cluster validity indices for ADORA2A dataset.
Number of Clusters
2
3
4

Davies Bouldin-Index
1.16
0.91
0.92

Silhouette Index
0.33
0.35
0.33

From Figure 4.3 we note that there is a huge drop in WCSS at number of
clusters=2 and 3 and later on there is a slight decrease. We have calculated cluster
validity indices and from Table 4.2 we can observe that the number of optimal clusters
chosen are 3 as DB-Index is less and Silhouette Index is high comparatively to other
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Figure 4.3: Optimal number of clusters for OPRK1 dataset using Elbow method

Table 4.2: Cluster validity indices for OPRK1 dataset.
Number of Clusters
2
3
4

Davies Bouldin-Index
1.11
0.89
0.9

Silhouette Index
0.357
0.37
0.33

number of clusters. Hence for OPRK1 dataset we have chosen number of optimal
clusters K=3.

4.2.2

Data visualization of majority class samples belonging to ADORA2A
and OPRK1 dataset.
In this section we present the visualization results of our clusters belonging to

ADORA2A and OPRK1 dataset. We have illustrated the datasamples belonging to
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the majority class on a 2D space, where we have visualized the clusters by performing
the K-Means clustering-based undersampling techinque.

Figure 4.4: Visualization of datasamples belonging to majority class before
performing K-Means undersampling technique on ADORA2A dataset.

As inferred from Figure 4.4 the original data belonging to majority class
has been distributed across 3 clusters and they are not well separated. Our goal
is to remove the datasamples that are far from the centroid and preserve only the
datasamples that are near to the centroid.
From Figure 4.5 it is observed that the datasamples that are far from the
centroid are eliminated and the clusters obtained after performing the K-Means
undersampling technique are well separated and compact with DB-Index=0.588 and
Silhouette Index=0.57. Now, only the important datasamples will be used for our
Methodology 2 classification. The experimental results are further illustrated in
Section 4.3.
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Figure 4.5: Visualization of datasamples belonging to majority class after performing
K-Means undersampling technique on ADORA2A dataset using mode.

Figure 4.6: Visualization of datasamples belonging to majority class before
performing K-Means undersampling technique on OPRK1 dataset.

From Figure 4.6 we can observe the data belonging to majority class has been
distributed across 3 clusters. We also observe that there are outliners in addition to
the datapoints that are least important i.e. far from the centroid of each cluster.
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Figure 4.7: Visualization of datasamples belonging to majority class after performing
K-Means undersampling technique on OPRK1 dataset.

As we can see from Figure 4.7 the datasamples that are far from the centroid
are eliminated and the clusters obtained after performing the K-Means undersampling
technique are well separated and compact with DB-Index=0.43 and Silhouette
Index=0.63. This implies that only the important datasamples will be used for our
Methodology 2 classification and the results are further illustrated in the Section 4.3.

4.3

Computational Evaluation of Supervised Learning using K-Means
Undersampling technique for ADORA2A and OPRK1 datasets.

This section gives the computational evaluation of supervised learning performed
on ADORA2A and OPRK1 dataset using the proposed K-Means clustering-based
undersampling approach.
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Computational evaluation on ADORA2A dataset:
Case 1: Training set biased population of class 0 samples: Table 4.3 gives
the per-class samples present in accordance to the various training sizes considered.

Table 4.3: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
202
1945
413
1734
628
1519

class 1 samples
Training Testing
97
753
186
664
271
579

From Table 4.4, it can be noted that LR identified 151 TPs from 579 samples
of class 1 and 1313 TNs from 1519 samples of class 0 for a training size of 30%. Thus,
the observed results across all cases validate our argument that LR has the best
classification performance for detection of TNs or non-drug conformations.

Table 4.4: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
222
188
151

Methodology 1 Classifier
T N1 F N1 F P1 Acc
1577 531 368 66.7
1449 476 285 68.2
1313 428 206 69.7

- LR
Se
Sp
0.29 0.81
0.28 0.83
0.26 0.864

From Table 4.5, it can be seen that GB identified 279 TPs from 579 samples of
class 1 and 1059 TNs from 1519 samples of class 0 for a training size of 30%. Similarly,
KNN identified 149 TPs from 579 samples of class 1 and 1245 TNs from 1519 samples
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of class 0 for a training size of 30%. Thus, it can be noted that overall GB had the
best classification performance as a Methodology 2 classifier with better detection
rates of TPs or potential drug candidate conformations over KNN classifier.

Table 4.5: Classification performance of Methodology 2 Classifier- GB and KNN on
the original training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
463
331
279

T P2
224
188
149

Methodology 2 Classifier - GB
T N2 F N2 F P2 Acc
Se
1185 290 760 61.08 0.614
1165 333 569 62.3
0.49
1059 300 460 63.7
0.48

Methodology
T N2 F N2
1578 529
1424 476
1245 430

2 Classifier F P2 Acc
367 66.7
310 67.2
274 66.4

Sp
0.6
0.67
0.69

KNN
Se
Sp
0.29 0.81
0.28 0.82
0.25 0.81

Case 2: New training set with biased population of class 1 samples
In this case, we have defined a new training dataset where we have performed the
proposed K-Means undersampling technique to remove the majority datasamples
followed by SMOTE technique to increase the minority datasamples in our original
training dataset.Table 4.6 gives the per-class distribution in the new training dataset.
We made sure that our learning time remains the same and hence we have added the
synthetic datasamples of our minority class based on the below formula:

N umber of class 1 samples to be added = TD − N0 − N1
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(4.4)

where TD =Total number of data samples in the original training dataset, N0 =Number
of class 0 samples obtained after K-means undersampling technique and N1 =Total
number of class 1 samples in the original training dataset.
For example, in the original training dataset the number of samples in class
0 is 628 and number of samples in class 1 is 271 for training size of 30%. Now,
after performing K-Means undersampling technique we have obtained 241 important
data samples belonging to class 0. Hence, in the new training dataset the number
of synthetic samples of class 1 to be added should be equal to 387 datasamples (i.e.
899-241-271=387 data samples). Hence, our new training dataset contains 241 class 0
samples and 271+387=658 class 1 samples.
From Table 4.6 results, we observe that the size of new training dataset is same
as the size of original training dataset and hence there is no net increase in learning
time.
Table 4.6: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
54
1945
147
1734
241
1519

class 1 samples
Training Testing
245
753
452
664
658
579

Table 4.7 describes the overall improved classification performance of two-stage
classification approach and the effects of induced class imbalance of class 1 sample
population. From Table 4.7, SMOTE-GB identified 396 TPs which is more than the
279 TPs identified using the original training dataset in Table 4.5 for the training
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size of 30%. In particular, SMOTE-KNN classifier had the best Methodology 2
classification performance, wherein it identified 496 TPs which is more than the 149
TPs identified using the original training dataset in Table 4.5 for the training size of
30%. The effects of induced class imbalance are evident from the boost in classification
performance of both the Methodology 2 classifiers. In particular, SMOTE-KNN
technique works on the concept of nearest neighbor algorithm and more induced
neighbors via oversampling of class 1 samples implies better statistical conclusion of
the underlying population distribution of the potential drug candidate conformations.

Table 4.7: Classification performance of SMOTE-GB and SMOTE-KNN on the new
training dataset.
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
T P2 T N2 F N2 F P2 Acc Se
Sp
515 765 238 1180 47.4 0.68 0.39
470 748 194
986 50.7 0.7 0.43
396 679 183
840 51.2 0.68 0.44

%Training
Size
10
20
30

Methodology 2 Classifier
T P2 T N2 F N2 F P2
662 408
91
1537
570 468
94
1266
496 407
83
1112

- SMOTE-KNN
Acc Se
Sp
39.6 0.87 0.2
43.2 0.85 0.26
43 0.85 0.26

From Table 4.7 we infer, the TP detection has been maximized using the
proposed KMeans clustering-based undersampling technique in comparison to random
undersampling approach. This is because, in the earlier experiment (Section 3.5.1)
random undersampling has removed N samples from the dataset randomly. Thus,
there are high chances that the resultant dataset contained datapoints that are less
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important features or outliners belonging to majority class. Thus, when SMOTE was
applied on the resultant dataset, the datapoints belonging to class 1 label might have
considered the datapoints belonging to class 0 label as their neighbouring datapoints
while generating synthetic samples. In general, SMOTE is not well-equipped to handle
such problems, so this might have increased the overlapping of classes and hence
ultimately might have reduced the detection rates of TP due to misclassification. The
proposed method’s goal is to remove the data samples that are less important, outliers
belonging to class 0 hence there are very less chances of datapoints belonging to class
1 to consider datapoints belonging to class 0 as their neighbouring datapoints during
SMOTE analysis. Thus the detection of TP has been maximized in this case which is
the utmost goal of Methodology 2 classification.
Table 4.8 describes the overall TPs and TNs reconfirmed and identified,
including the unique TPs and TNs identified by the Methodology 2 classifier. For the
training size of 30% SMOTE-GB reconfirmed on 133 TPs identified by Methodology
1 classifier apart from identifying 263 new TPs. So, in total it identified 396 TPs
using the new training dataset. SMOTE-KNN classifier reconfirmed the 146 TPs
identified by Methodology 1 classifier aside from identifying 350 new TPs. So, in
total it identified 496 TPs using the new training dataset. Thereby, Table 4.8 further
demonstrates the effectiveness of the proposed two-stage sampling-based classification
approach using K-Means undersampling technique.
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From Table 4.8 we infer that on using the proposed KMeans undersampling
technique, the model has identified a good number TPs and has also reconfirmed on
good number of TNs comparatively to Section 3.5.1 results for ADORA2A dataset.

Table 4.8: Reconfirmation and identification of new TP and new TN by Methodology
2 classifiers- SMOTE-GB and SMOTE-KNN

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
333
75
182
690
307
50
163
698
263
45
133
634

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
446
21
216
387
394
11
176
457
350
14
146
393

Case 3: Decision Fusion

Table 4.9: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
81.8
73.7
84.9
20
83.1
74.5
86.4
30
84.4
71
89

Table 4.9 demonstrates the overall classification performance of the proposed
decision fusion case. From Table 4.9 and Figure 4.8-Figure 4.10 and it can be inferred
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Table 4.10: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-KNN
Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy T Pacc T Nacc
10
83.9
88.7
82.1
20
85.1
87.6
84.1
30
87.1
86
87.3

that the overall classification performance of the proposed methods: LR+SMOTE-GB
and LR+SMOTE-KNN techniques were significantly superior to individual classification
performance of LR, GB and KNN classifiers as given in Table 4.4-Table 4.5.

Figure 4.8: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein ADORA2A.

From Figure 4.8- Figure 4.10, we can infer that, LR+SMOTE-KNN had
excellent classification performance for identification of the molecular conformations
for protein ADORA2A in terms of overall classification accuracy and TP accuracy
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Figure 4.9: TP accuracies across varying training sizes for case 1, case 2 and decision
fusion for protein ADORA2A.

Figure 4.10: TN accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein ADORA2A.

measures.
Computational evaluation on OPRK1 dataset:
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Case 1: Training set biased population of class 0 samples:
Table 4.11 gives the per-class distribution in accordance to the various training sizes
considered.

Table 4.11: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
289
2573
574
2288
858
2004

class 1 samples
Training Testing
10
127
25
112
41
96

From Table 4.12, the observed results across all cases validate our argument
that LR has the best classification performance for detection of TNs or non-drug
conformations due to the class imbalance problem.

Table 4.12: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
3
1
0

Methodology 1 Classifier - LR
T N1 F N1 F P1 Acc Se
2531 124
42 93.8 0.02
2282 111
6
95.1
0
2001
96
3
95.2
0

Sp
0.98
0.99
0.99

From Table 4.13, it can be seen that GB identified 51 TPs from 96 samples of
class 1 and 804 TNs from 2004 samples of class 0 for a training size of 30%. Similarly,
KNN couldn’t identify any TPs from 96 samples of class 1 but identified 100% of
TNs of class 0 samples for a training size of 30% due to the class imbalance problem.
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Thus, it can be noted that overall GB had the best classification performance as a
Methodology 2 classifier with better detection rates of TPs or potential drug candidate
conformations over KNN classifier.

Table 4.13: Classification performance of Methodology 2 Classifier- GB and KNN
on the original training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
27
45
51

Methodology 2 Classifier T N2 F N2 F P2 Acc
1983 100
590 74.44
1186
67
1102 51.2
804
45
1200 40.7

GB
Se
0.21
0.4
0.5

Sp
0.77
0.51
0.4

Methodology 2 Classifier - KNN
T P2 T N2 F N2 F P2 Acc Se Sp
0
2573 127
0
95.2 0
1
0
2287 112
1
95.2 0 0.99
0
2004
96
0
95.4 0
1

Case 2: New training set with biased population of class 1 samples
Table 4.14 gives the per-class distribution in the new training dataset. From Table 4.14
results, we observe that the size of new training dataset is same as the size of original
training dataset. The synthetic samples of class 1 are added to our new training
dataset based on equation (4.4)
From Table 4.15, SMOTE-GB identified 70 TPs and SMOTE-KNN identified
68 TPs which is more than the TPs identified using the original training dataset
in Table 4.13 for the training size of 30%. The effects of induced class imbalance
are evident from the boost in classification performance of both the Methodology 2
classifiers.
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Table 4.14: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
135
2573
163
2288
273
2004

class 1 samples
Training Testing
164
127
436
112
626
96

Table 4.15: Classification performance of SMOTE-GB and SMOTE-KNN on the
new training dataset.
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
T P2 T N2 F N2 F P2 Acc Se
Sp
30 2007
97
566 75.4 0.23 0.78
83
834
29
1454 38.2 0.74 0.36
70
742
26
1262 38.6 0.72 0.37

From Table 4.16 for the training size of 30% Methodology 1 classifier couldn’t
identify any TP, but SMOTE-GB identified 70 new TPs and SMOTE-KNN classifier
identified 68 new TPs. From Table 4.17 we can also infer that the proposed K-Means
undersampling technique identified a good number TPs and also reconfirmed a good
number of TNs comparatively to Section 3.5.1 results for OPRK1 dataset.
Case 3: Decision Fusion
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
T P2 T N2 F N2 F P2 Acc Se
Sp
36 1686
91
887 63.7 0.28 0.65
77
950
35
1338 42.7 0.68 0.415
68
812
28
1192 41.9 0.7
0.4
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Table 4.16: Reconfirmation and identification of new TP by Methodology 2 classifiersSMOTE-GB

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
27
19
3
1988
82
1
1
833
70
2
0
740

Table 4.17: Reconfirmation and identification of new TP by Methodology 2 classifiersSMOTE-KNN
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
34
14
2
1672
76
1
1
949
68
0
0
812

Table 4.18: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
95.5
23.6
94.4
20
98.5
74.1
99.7
30
98.7
72.9
99.9
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Table 4.19: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-KNN
Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy TP acc TN acc
10
95.6
29
94.2
20
98.3
68.7
99.7
30
98.5
70.8
99.8

Table 4.18 demonstrates the overall classification performance of the proposed
decision fusion case. From Table 4.18 and Figure 4.11- Figure 4.13, both LR+SMOTE-GB
and LR+SMOTE-KNN had excellent classification performance for identification of
the molecular conformations for protein OPRK1 in terms of overall classification
accuracy and LR+SMOTE-GB had excellent classification performance TP accuracy
measures.

Figure 4.11: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein OPRK1.
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Figure 4.12: TP accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein OPRK1.

Figure 4.13: TN accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein OPRK1.

Thus far we have discussed the idea behind proposing K-Means clustering-based
Undersampling approach over random undersampling approach. We have also experimentally
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validated the effectiveness of the proposed approach on proteins ADORA2A and
OPRK1.

4.4

Experiment 2: Supervised Learning with Feature Selection

This section demonstrates the experimental evaluation of supervised learning
performed on reduced ADORA2A and OPRK1 datasets after applying feature selection
techniques.

4.4.1

Feature Selection analysis on ADORA2A and OPRK1 datasets.
a) ADORA2A Dataset: The feature selection techniques ANOVA, Mutual

Information and Extra Trees Classifier had been applied on the ADORA2A dataset.
Based on majority voting, the features that had high importance in predicting the
output variable has been selected.

Figure 4.14: Feature importance using Mutual Information Technique on ADORA2A
dataset.
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Figure 4.15: Feature importance using ANOVA on ADORA2A dataset.

Figure 4.16: Feature importance using Extra Trees Classifier as feature selection
technique on ADORA2A dataset.

From Figures 4.14 - 4.16, we can infer that there are overall 23 features identified
as the important information in predicting the output variable (protein conformation)
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using mutual information, ANOVA and extra trees classifier as feature selection
techniques. The selected features are as listed in the Table 4.19:

Table 4.20: Selected subset of features for ADORA2A dataset
List of features
pro pl 3D
pro coeff diff
pro r solv
pro eccen
pro asa hyd
pro volume
pro henry
pro dipole moment
pro zquadrupole
pro patch hyd n
pro patch ion n
pro patch pos

List of features
pro coeff fric
pro r gyr
pro sed const
pro asa vdw
pro asa hph
pro helicity
pro app charge
pro hyd moment
pro patch hyd
pro patch ion
pro patch neg n

b) OPRK1 : The feature selection techniques ANOVA, Mutual Information and
Extra Trees Classifier has been employed on the OPRK1 dataset. Based on majority
voting, the features that had high importance in predicting the protein conformation
had been selected.
From Figures 4.17 - 4.19, we can infer that there are overall 21 features identified
as the important ones in predicting the output variable using mutual information,
ANOVA and extra trees classifier as feature selection techniques. The selected features
as tabulated in Table 4.20:
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Figure 4.17: Feature importance using Mutual Information Technique on OPRK1
dataset.

Figure 4.18: Feature importance using ANOVA on OPRK1 dataset.

4.4.2

Experimental evaluation of supervised learning on reduced datasets
ADORA2A and OPRK1 using K-Means undersampling technique
After feature selection has been performed on the respective datasets, the
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resultant reduced the datsets are applied to our proposed two-stage K-Means sampling-based

Figure 4.19: Feature importance using Extra Trees Classifier as feature selection
technique on OPRK1 dataset.

Table 4.21: Selected subset of features for OPRK1 dataset
List of features
pro pl 3D
pro asa vdw
pro asa hph
pro helicity
pro patch hyd 1
pro patch hyd 3
pro patch hyd 4
pro patch hyd 5
pro patch ion
pro patch ion 2
pro patch pos

List of features
pro r gyr
pro asa hyd
pro volume
pro hyd moment
pro zquadrupole
pro patch neg 1
pro patch neg 2
pro patch neg 3
pro patch neg 5
pro patch neg n

classifier approach. This section illustrates the experimental evaluation of supervised
learning performed on the reduced datasets of ADORA2A and OPRK1 dataset using
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the proposed K-Means clustering-based undersampling approach.

Experimental validation on ADORA2A dataset:
Case 1: Training set biased population of class 0 samples:
Table 4.22 gives the per-class samples present in accordance to the various training
sizes considered.

Table 4.22: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
202
1945
413
1734
628
1519

class 1 samples
Training Testing
97
753
186
664
271
579

From Table 4.23, it can be noted that LR identified 109 TPs from 579 samples
of class 1 and 1363 TNs from 1519 samples of class 0 for a training size of 30%. Thus,
the observed results across all cases validate our argument that LR has the best
classification performance for detection of TNs or non-drug conformations.

Table 4.23: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
203
175
109

Methodology 1 Classifier - LR
T N1 F N1 F P1 Acc
Se
1606 550 339
67 0.269
1476 489 258 68.8 0.26
1363 470 156 70.1 0.18
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Sp
0.825
0.85
0.89

From Table 4.24, it can be seen that GB identified 364 TPs from 579 samples of
class 1 and 889 TNs from 1519 samples of class 0 for a training size of 30%. Similarly,
KNN identified 137 TPs from 579 samples of class 1 and 1238 TNs from 1519 samples
of class 0 for a training size of 30%. Thus, it can be noted that overall GB had the
best classification performance as a Methodology 2 classifier with better detection
rates of TPs or potential drug candidate conformations over KNN classifier.

Table 4.24: Classification performance of Methodology 2 Classifier- GB and KNN
on the original training dataset.
%Training
Size
10
20
30

%Training
Size
10
20
30

T P2
478
441
364

Methodology 2 Classifier
T N2 F N2 F P2 Acc
1163 275 782 60.8
980
223 754 59.2
889
215 630 59.7

Methodology
T P2 T N2 F N2
217 1531 536
203 1400 461
137 1238 442

- GB
Se
0.634
0.66
0.62

2 Classifier F P2 Acc
414 64.7
334 66.8
281 65.5

Sp
0.597
0.565
0.58

KNN
Se
Sp
0.28 0.78
0.3
0.8
0.23 0.81

Case 2: New training set with biased population of class 1 samples
In this case, we have defined a new training dataset where we have performed the
proposed K-Means undersampling technique to remove the majority datasamples
followed by SMOTE technique to increase the minority datasamples in our original
training dataset. The number of optimal clusters chosen to perform KMeans based
undersampling method is shown in Figure 4.20. We can clearly observe that the
number of optimal clusters=2 as the elbow exists at Number of clusters=2. Also, from
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Table 4.25 we can observe that at number of clusters=2 the Davies Bouldin-Index is
less i.e. 0.88 and Silhouette Index is high i.e. 0.42 compared to others. Hence we have
chosen number of optimal clusters=2.

Figure 4.20: Optimal number of clusters for Reduced ADORA2A dataset obtained
on Feature selection using Elbow method

Table 4.25: Cluster validity indices for Reduced ADORA2A dataset obtained on
Feature selection.
Number of Clusters
2
3
4

Davies Bouldin-Index
0.88
1.03
0.9

Silhouette Index
0.42
0.32
0.34

Table 4.26 gives the per-class distribution in the new training dataset. We
made sure that our learning time remains the same and hence we have added the
synthetic datasamples of our minority class based on equation (4.4). From Table 4.26
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results, we observe that the size of new training dataset is same as the size of original
training dataset and hence there is no increase in data-learning time.

Table 4.26: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
66
1945
169
1734
236
1519

class 1 samples
Training Testing
233
753
430
664
663
579

Table 4.27 describes the overall improved classification performance of two-stage
classification approach and the effects of induced class imbalance of class 1 sample
population. From Table 4.27, SMOTE-GB identified 437 TPs which is more than the
364 TPs identified using the original training dataset in Table 4.24 for the training
size of 30%. In particular, SMOTE-KNN classifier had the best Methodology 2
classification performance, wherein it identified 470 TPs which is more than the 137
TPs identified using the original training dataset in Table 4.24 for the training size of
30%. The effects of induced class imbalance are evident from the boost in classification
performance of both the Methodology 2 classifiers.

Table 4.27: Classification performance of SMOTE-GB and SMOTE-KNN on the
new training dataset.
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
T P2 T N2 F N2 F P2 Acc
Se
Sp
562 465 191 1480 38
0.74 0.23
475 890 189
844 56.9 0.715 0.51
437 700 142
819 54.1 0.75 0.46
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%Training
Size
10
20
30

Methodology 2 Classifier
T P2 T N2 F N2 F P2
623 377 130 1568
531 636 133 1098
470 470 109 1049

- SMOTE-KNN
Acc Se
Sp
37 0.82 0.19
48.6 0.79 0.36
44.8 0.81 0.3

Table 4.28 describes the overall TPs and TNs reconfirmed and identified,
including the unique TPs and TNs identified by the Methodology 2 classifier. For the
training size of 30% SMOTE-GB reconfirmed on 109 TPs identified by Methodology
1 classifier apart from identifying 328 new TPs. So, in total it identified 437 TPs
using the new training dataset. SMOTE-KNN classifier reconfirmed the 101 TPs
identified by Methodology 1 classifier aside from identifying 369 new TPs. So, in total
it identified 470 TPs using the new training dataset. Thereby, Table 4.28 further
demonstrates the effectiveness of the proposed two-stage sampling-based classification
approach using K-Means undersampling technique on the reduced ADORA2A dataset.
The reduced dataset has identified more number of TP compared to the original
dataset using the proposed K-Means undersampling technique. This shows that the
selected features played an excellent role in determining the target variable.

From Table 4.28 we infer that the proposed K-Means undersampling technique
was effective on the reduced dataset of ADORA2A. On an average, the model has
identified a good number TPs and has also reconfirmed on good number of TNs
comparatively to Section 4.3 results for ADORA2A dataset.
Case 3: Decision Fusion:
Table 4.29 demonstrates the overall classification performance of the proposed decision
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Table 4.28: Reconfirmation and identification of new TP and new TN by Methodology
2 classifiers- SMOTE-GB and SMOTE-KNN

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
364
19
198
446
303
3
172
887
328
0
109
700

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
369
5
101
465
369
12
162
624
431
18
192
431

Table 4.29: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB and LR+SMOTE-KNN
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
81.2
75.2
83.2
20
81.6
71.9
85.2
30
85.7
75.2
83.2

Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy TP acc TN acc
10
83.6
84.1
83.4
20
84.7
81.9
85.8
30
87.9
82.5
90
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fusion case. From Table 4.29 and Figures 4.21-Figure 4.23 and it can be inferred that
the overall classification performance of the proposed methods: LR+SMOTE-GB and
LR+SMOTE-KNN techniques were significantly superior to individual classification
performance of LR, GB and KNN classifiers as given in Table 4.23-Table 4.24.

Figure 4.21: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein ADORA2A after feature selection.

From Figures 4.21- Figure 4.23, we can infer that, LR+SMOTE-KNN had
excellent classification performance for identification of the molecular conformations
for protein ADORA2A in terms of overall classification accuracy and TP accuracy
measures.
Experimental validation on OPRK1 dataset:
Case 1: Training set biased population of class 0 samples:
Table 4.30 gives the per-class distribution in accordance to the various training sizes
considered.
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Figure 4.22: TP accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein ADORA2A after feature selection.

Figure 4.23: TN accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein ADORA2A after feature selection.

From Table 4.31, the observed results across all cases validate our argument
that LR has the best classification performance for detection of TNs or non-drug
conformations due to the class imbalance problem.
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Table 4.30: Number of class 0 samples and class 1 samples in the original training
dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
289
2573
574
2288
858
2004

class 1 samples
Training Testing
10
127
25
112
41
96

Table 4.31: Classification performance of Methodology 1 Classifier-LR on the original
training dataset.
%Training
Size
10
20
30

T P1
0
0
0

Methodology 1 Classifier - LR
T N1 F N1 F P1 Acc Se
2573 127
0
95.2 0
2288 112
0
95.4 0
2004
96
0
95.4 0

Sp
1
1
1

From Table 4.32, it can be seen that GB identified only 1 TP from 96 samples of
class 1 and 1997 TNs from 2004 samples of class 0 for a training size of 30%. Similarly,
KNN couldn’t identify any TPs from 96 samples of class 1 but identified 100% of TNs
of class 0 samples for a training size of 30% due to the class imbalance problem.

Table 4.32: Classification performance of Methodology 2 Classifier- GB and KNN
on the original training dataset.
%Training
Size
10
20
30

T P2
5
0
1

Methodology 2 Classifier - GB
T N2 F N2 F P2 Acc Se
2461 122 112 91.3 0.03
2251 112
37 93.7
0
1997
95
7
95.1 0.01
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Sp
0.95
0.98
0.99

%Training
Size
10
20
30

Methodology 2 Classifier - KNN
T P2 T N2 F N2 F P2 Acc Se Sp
0
2573 127
0
95.2 0
1
0
2288 112
0
95.4 0
1
0
2004
96
0
95.4 0
1

Case 2: New training set with biased population of class 1 samples
Table 4.34 gives the per-class distribution in the new training dataset. The number of
optimal clusters chosen to perform K-Means based undersampling method is shown
in Figure 4.24. We can observe that the number of optimal clusters=3 as the elbow
exists at number of clusters=3. Also, from Table 4.33 we can observe that at number
of clusters=3 the Davies Bouldin-Index is less i.e. 0.94 and Silhouette Index is high
i.e. 0.33 compared to others. Hence the number of optimal clusters K=3 was selected.

Figure 4.24: Optimal number of clusters for Reduced OPRK1 dataset obtained on
Feature selection using Elbow method
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Table 4.33: Cluster validity indices for Reduced OPRK1 dataset obtained on Feature
selection.
Number of Clusters
2
3
4

Davies Bouldin-Index
1.22
0.94
0.94

Silhouette Index
0.31
0.33
0.31

From Table 4.34 results, we observe that the size of new training dataset is
same as the size of original training dataset. The synthetic samples of class 1 are
added to our new training dataset based on equation (4.4)

Table 4.34: Number of class 0 samples and class 1 samples in new training dataset.

%Training
Size
10
20
30

class 0 samples
Training Testing
96
2573
256
2288
253
2004

class 1 samples
Training Testing
203
127
343
112
656
96

From Table 4.35, SMOTE-GB identified 53 TPs and SMOTE-KNN identified
62 TPs which is more than the TPs identified using the original training dataset
in Table 4.32 for the training size of 30%. The effects of induced class imbalance
are evident from the boost in classification performance of both the Methodology 2
classifiers.
From Table 4.36 it can be noted that for training size of 30% Methodology
1 classifier couldn’t identify any TP, but SMOTE-GB identified 53 new TPs and
SMOTE-KNN classifier identified 62 new TPs. From Table 4.36 we infer that on
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Table 4.35: Classification performance of SMOTE-GB and SMOTE-KNN on the
new training dataset.
%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
T P2 T N2 F N2 F P2 Acc Se
Sp
22 2074 105
499 77.6 0.17 0.8
37 1425
75
863 60.9 0.33 0.62
53
679
43
1325 34.8 0.55 0.33

%Training
Size
10
20
30

Methodology 2 Classifier
T P2 T N2 F N2 F P2
49 1470
78
1103
41 1495
71
793
62
806
34
1198

- SMOTE-KNN
Acc Se
Sp
56.2 0.38 0.57
64 0.36 0.65
41.3 0.64 0.4

using the proposed K-Means undersampling technique, our model has identified a
good number TPs and has also reconfirmed on good number of TNs comparatively to
Section 4.3 results for OPRK1 dataset.

Table 4.36: Reconfirmation and identification of new TP by Methodology 2 classifiersSMOTE-GB and SMOTE-KNN

%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-GB
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
22
0
0
2074
37
0
0
1425
53
0
0
679

Table 4.37 demonstrates the overall classification performance of the proposed
decision fusion case. From Table 4.37 and Figures 4.25- Figure 4.27 both LR+SMOTE-GB
and LR+SMOTE-KNN had excellent classification performance for identification of
the molecular conformations for protein OPRK1 in terms of overall classification
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%Training
Size
10
20
30

Methodology 2 Classifier - SMOTE-KNN
N ew T P2 N ew T N2 T P2 reconf irmed T N2 reconf irmed
49
0
0
1470
41
0
0
1495
62
0
0
806

accuracy and LR+SMOTE-GB had excellent classification performance TP accuracy
measures. We can clearly observe that by implementing the pipeline on the selected
features we have obtained good performance and hence the selected features are
considered to be very important in determining the binding state of the conformations.

Table 4.37: Decision Fusion of Methodology 1 classifier and Methodology 2 classifier
system: LR+SMOTE-GB and LR+SMOTE-KNN
Decision fusion: LR+SMOTE-GB
%Training size Total accuracy TP acc TN acc
10
96.11
17.3
100
20
96.8
33
100
30
97.9
55.2
100

Decision fusion: LR+SMOTE-KNN
%Training size Total accuracy TP acc TN acc
10
97.1
38.5
100
20
97
36.6
100
30
98.3
64.5
100

Case 3: Decision Fusion:
In this section, we have discussed the contribution of feature selection in determining
the protein conformational selection. We have selected the features based on their
information importance as given by the feature selection techniques. The proposed
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Figure 4.25: Overall classification accuracies across varying training sizes for case 1,
case 2 and decision fusion for protein OPRK1 after feature selection.

Figure 4.26: TP accuracies across varying training sizes for case 1, case 2 and
decision fusion for protein OPRK1 after feature selection.

two-stage K-Means clustering based sampling pipeline was evaluated on the selected
features of the protein datasets.
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Figure 4.27: Plot of TN accuracies across varying training sizes for case 1, case 2
and decision fusion for protein OPRK1 after feature selection.

4.5

Summary

In this chapter we presented the proposed K-Means clustering-based undersampling
method. We have also experimentally evaluated the performance of the proposed
methodology in Section 4.2, and Section 4.4. From these experiments, we have
countered the class imbalance problem and maximized the detection of potential
drug-candidate conformations and non-drug candidate conformations using the proposed
two-stage sampling-based classifier model.
From ML perspective, we obtained excellent detection of TPs using our proposed
two-stage sampling based classifier. We can compare from Table Table 3.9,Table
Table 4.7, Table Table 4.27, Feature selection followed by our proposed KMeans
underdersampling method gave excellent performance in detecting maximum number
of TPs for ADORA2A dataset, whereas from Table Table 3.17, Table Table 4.15,
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Table Table 4.35, Random undersampling-SMOTE approach has excelled in detecting
maximum number of TPs for OPRK1 dataset.
From clinical point of view, when the predicted conformations were tested in
the lab using software simulations such as MOE and MD, it was observed that all the
methods resulted in the same value of precision ranging from 0.30-0.38 for ADORA2A
dataset and 0.03-0.06 for OPRK1 dataset irrespective of the sampling strategy we
implement where Precision is defined as,

P recision =

T P2
T P2 + F P 2

. In order to understand the reason behind the same precision values we had explored
the data distribution patterns for the datasets ADORA2A and OPRK1. This problem
is further illustrated and discussed in Chapter 5.
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CHAPTER 5

DATA DISTRIBUTION PATTERNS FOR ADORA2A AND OPRK1

One of key roles before performing pre-clinical lab trials is to calculate Enrichment
Ratio for the conformations selected for a protein. In this chapter we will discuss
about the data distribution patterns for ADORA2A and OPRK1 datasets. Learning
the data patterns is one of the essential tasks in order to understand the reason behind
similar values of enrichment ratio.

5.1

Data distribution patterns for ADORA2A dataset

We had observed that the dataset gives same values of precision (range of
0.30-0.38) irrespective of the methodology we use. Therefore, we had performed
an experiment using only three sampling strategies alone and they are Random
undersampling, SMOTE, KMeans undersampling method on training sizes 30% and
70%. Table 5.1 gives the per-class distribution in the testing dataset.

Table 5.1: Number of class 0 samples and class 1 samples in test dataset
%Training size
30
70

Number of zeros
1519
647
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Number of ones
579
253

From Table 5.2 we observe that the precision values are same for training sizes
30% and 70% irrespective of the sampling strategy we use. In this experiment, we note
that both random undersampling and SMOTE had performed well in detecting TPs
because the dataset in these cases is balanced, i.e. equal number of zeros and ones in
training phase, whereas the KMeans undersampling technique performed almost in
par with the other two sampling strategies and delivered same range of precision even
through the dataset was not balanced in this case.

Table 5.2: Prediction of molecular conformations using three different sampling
strategies- GB classifier.
Technique
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

%Training size
30

TP
343

TN
905

FN
236

FP
614

Acc
59.4

Precision
0.35

70

152

382

101

265

59.3

0.36

30
70
30

347
152
347

908
379
842

232
101
232

611
268
677

59.8
59
56.6

0.36
0.36
0.33

70

134

343

119

304

53

0.305

From Table 5.3 we observe that random undersampling and SMOTE techniques
performed very well in predicting TPs using KNN classifier. KMeans undersampling
method had predicted good number of TNs and therefore FPs reduced in this case
and hence we observe that the precision values are in same range irrespective of the
sampling strategy we use.
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(a) Histogram of pro mass

(b) Histogram of pro pl 3D

(c) Histogram of pro coeff fric

(d) Histogram of pro coeff diff

(e) Histogram of pro r gyr

(f) Histogram of pro r solv

Figure 5.1: Histogram of ADORA2A features (1-6).
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Table 5.3: Prediction of molecular conformations using three different sampling
strategies- KNN classifier.
Technique
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

5.1.1

%Training size
30

TP
357

TN
820

FN
222

FP
699

Acc
56.1

Precision
0.33

70

162

363

91

284

58.3

0.36

30
70
30

390
166
290

722
302
927

189
87
289

797
345
592

53
52
58

0.32
0.324
0.32

70

124

409

129

238

59.2

0.34

Statistical distribution patterns of ADORA2A dataset using Histograms
From Figure 5.1-5.9 it can be inferred that the distribution of data is largely

symmetric and features are very similar to each other. Thus the datapoints have
almost same the amount of information distribution. Only a few features exhibited
asymmetric data distribution. In such cases we can select a subset of good features
amongst them for dimensionality reduction and information preservation purposes.

5.1.2

Inferences
Overall, we observe that all the identified features from the feature selection

techniques (From Section 4.4) have normal distribution and are symmetric in nature.
If we consider the entire dataset, we can see that some features have skewness and
hence this might be one of the reasons for misclassifications. In this case, if we consider
all the features then there is some asymmetric distribution in our dataset whereas,
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(a) Histogram of pro sed const

(b) Histogram of pro eccen

(c) Histogram of pro asa vdw

(d) Histogram of pro asa hyd

(e) Histogram of pro asa hph

(f) Histogram of pro volume

Figure 5.2: Histogram of ADORA2A features (7-12).
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(a) Histogram of pro mobility

(b) Histogram of pro helicity

(c) Histogram of pro henry

(d) Histogram of pro net charge

(e) Histogram of pro app charge

(f) Histogram of pro dipole moment

Figure 5.3: Histogram of ADORA2A features (13-18).
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(a) Histogram of pro hyd moment

(b) Histogram of pro zeta

(c) Histogram of pro zdipole

(d) Histogram of pro zquadrupole

(e) Histogram of pro patch hyd

(f) Histogram of pro patch hyd 1

Figure 5.4: Histogram of ADORA2A features (19-24).
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(a) Histogram of pro patch hyd 2

(b) Histogram of pro patch hyd 3

(c) Histogram of pro patch hyd 4

(d) Histogram of pro patch hyd 5

(e) Histogram of pro patch hyd n

(f) Histogram of pro patch ion

Figure 5.5: Histogram of ADORA2A features (25-30).
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(a) Histogram of pro patch ion 1

(b) Histogram of pro patch ion 2

(c) Histogram of pro patch ion 3

(d) Histogram of pro patch ion 4

(e)Histogram of pro patch ion 5

(f) Histogram of pro patch ion n

Figure 5.6: Histogram of ADORA2A features (31-36).
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(a) Histogram of pro patch neg

(b) Histogram of pro patch neg 1

(c) Histogram of pro patch neg 2

(d) Histogram of pro patch neg 3

(e) Histogram of pro patch neg 4

(f) Histogram of pro patch neg 5

Figure 5.7: Histogram of ADORA2A features (37-42).
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(a) Histogram of pro patch neg n

(b) Histogram of pro patch pos

(c) Histogram of pro patch pos 1

(d) Histogram of pro patch pos 2

(e) Histogram of pro patch pos 3

(f) Histogram of pro patch pos 4

Figure 5.8: Histogram of ADORA2A features (43-48).
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(a) Histogram of pro patch pos 5

(b) Histogram of pro patch pos n

Figure 5.9: Histogram of ADORA2A features (49-50).

all the identified selected features have normal distribution. Hence, we see some
improvement in the identification of TPs on using the selected features instead of
original features. This experiment also gives us a proof as to why the GB classifier
performs so well with the dataset than compared to other classifiers. This is because,
most of the features have normal distribution and can capture maximum amount of
variance or data distribution under the bell curve. As we can observe, there are same
number of datasamples belonging to class 1 and class 0 and the bell cuves of both the
groups/classes are ovelapping in most of the cases. There are no certain features which
could well distinguish between the datasamples belonging to class label 0 or1. There
are many features that are similar to each other and one way to achieve good value of
enrichment ratio is to have more number of datasamples with distinct features.
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5.1.3

Visualization of data patterns of ADORA2A dataset
In this section we understand the data patterns of ADORA2A dataset using

KMeans clustering technique. We performed elbow method on the entire dataset to
determine optimal number of clusters. From Figure 5.10 we observe that the optimal
number of clusters chosen is 2. In order to visualize the data patterns we performed 2
methods:
• PCA followed by K-Means clustering
• t-SNE followed by K-Means clustering.

Figure 5.10: Elbow method on original dataset-ADORA2A

1. PCA followed by K-Means clustering:

From Figure 5.11 (a) we observe that the there is an overlap between the
distribution of the datasamples belonging to class 0 and class1 because of the similar
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(a) Original dataset

(b) After K-Means clustering

(c) PCA Reduced dataset

(d) After PCA and K-Means clustering

Figure 5.11: Data distribution of ADORA2A before and after feature selection and
dimensionality reduction using PCA.

features in our dataset. PCA is employed on the original training dataset to obtain
the principle components such that maximum amount of variance is preserved. We
also observe that cluster1 contains less number of samples and the data distribution is
very sparse and contains many outliers. The number of datasamples that cluster 1
contains are 676 whereas cluster 2 contains 2321 datasamples. It’s clearly seen that
cluster 2 conatins maximum number of datasamples and there is no proper separation
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between the classes. The classes overlap and hence there is a misclassification when
we consider the entire dataset.
From Figure 5.11 (c) we observe that there is an equal distribution of datasamples
in both the clusters after feature selection. The datsamples are dense in each cluster
and contain less number of outliers. The number of datasamples in cluster 1 are
1629 and in cluster 2 are 1368. So, the selected features contribute in predicting the
ActiveBinding state, i.e. if the values of these features are high and good then those
conformations can be selected to bind with the protein.

1. t-SNE followed by K Means clustering:
The motivation behind using t-SNE is to reduce the overlap between the classes and
increase separation , because less overlap leads to less misclassification.
From Figure 5.12 (c) we observe that again there is an equal distribution of
datasamples in both the clusters after feature selection. The datsamples are dense in
each cluster and contain less number of outliers.The number of datasamples in cluster
1 are 1612 and in cluster 2 are 1385. ADORA2A consists 850 datasamples belonging
to class label 1 but the clusters obtained are having almost equal distribution of
datapoints. So, overall there are no certain features defined that could well distinguish
the datasamples beloning to class label 0 and class label 1 respectively.
Overall, we can conclude from statistical distributions and data patterns of
ADORA2A dataset that feature selection attributes play a vital role in determining
the ActiveBinding state of protein. Hence, this made us to perform the sampling
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(a) Original dataset using t-SNE

(b) After K-Means clustering

(c) t-SNE Reduced dataset

(d) After t-SNE and K-Means clustering

Figure 5.12: Data distribution of ADORA2A before and after feature selection and
dimensionality reduction using t-SNE.

strategies using only feature selection attributes. From Table 5.1 gives the per-class
distribution in the testing dataset.
Table 5.4 and Table 5.5 perform better than Table 5.2 and Table 5.3 on
maximizing the number of TPs for the cases random undersampling and SMOTE.
K-Means undersampling performs well in maximizing TNs which further reduces FPs,
but doesn’t give a good increase in TPs because of which we have the same precision
value. Overall, the methods have the same precision, but when the methods are
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Table 5.4: Prediction of molecular conformations using three different sampling
strategies with Feature selection (FS)- GB classifier.
Technique
using FS
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeans-g
Undersampling
KMeansUndersampling

%Training
size
30

TP

TN

FN

FP

Acc

Precision

421

758

158

761

56.1

0.35

70

181

339

72

308

57.7

0.37

30
70
30

398
182
360

804
336
798

181
71
158

715
311
761

57.2
57.5
56.1

0.35
0.36
0.35

70

148

388

105

259

59.5

0.36

performed on the identified feature selection attributes they perform excellent on
maximizing TP. Hence, we can conclude that the selected features contribute more
information towards class 1 labels. The reason behind having same precision is because
the dataset contains similar features and hence doesn’t contribute more in prediction
of both TPs and TNs. More number of datasamples with distinct features could
probably solve this problem.

5.2

Data distribution patterns for OPRK1 dataset

We had observed that the dataset gives same values of precision (range of
0.03-0.06) irrespective of the sampling strategy we use. Therefore, we had performed an
experiment using only three sampling strategies alone. They are random undersampling,
SMOTE, and K-Means undersampling method on training sizes 30% and 70%.
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Table 5.5: Prediction of molecular conformations using three different sampling
strategies- KNN classifier.
Technique
using FS
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

%Training
size
30

TP

TN

FN

FP

Acc

Precision

366

862

213

657

58.5

0.35

70

166

341

87

306

56.3

0.35

30
70
30

386
166
260

736
331
1031

193
87
319

797
316
488

53.4
55.2
61.5

0.33
0.34
0.34

70

89

473

164

174

62.4

0.33

Table 5.6: Number of class 0 samples and class 1 samples in test dataset
%Training size
30
70

Number of zeros
2004
862

Number of ones
96
38

Table 5.6 gives the per-class distribution in the testing dataset. From Table 5.7
we can observe that the precision values are same for training sizes 30% and 70%
irrespective of the sampling strategy we use. In this experiment we can observe
that both random undersampling and SMOTE had performed well in detecting TPs
because the dataset in these cases is balanced, i.e. equal number of zeros and ones
in training phase, whereas K-Means undersampling technique performed almost in
par with the other two sampling strategies and delivered same range of precision even
through the dataset was not balanced in this case.
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Table 5.7: Prediction of molecular conformations using three different sampling
strategies- GB classifier.
Technique
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

%Training
size
30

TP

TN

FN

FP

Acc

Precision

62

645

34

1359

33.6

0.04

70

29

135

9

727

18.2

0.03

30
70
30

43
21
59

856
263
1010

53
17
37

1148
599
994

42.8
31.5
50.9

0.03
0.03
0.05

70

26

448

12

414

52.6

0.05

From Table 5.8 we can observe that random undersampling and SMOTE
techniques performed very well in predicting TPs using KNN classifier. K-Means
undersampling method had predicted good number of TNs and therefore FPs reduced
in this case but it predicted 0 TPs which is not good in this case. This was because
the dataset was not balanced and still had good number of zeros than ones. Overall,
GB classifier performed well than KNN for OPRK1.

5.2.1

Statistical distribution patterns of OPRK1 dataset using Histograms

5.2.2

Inferences
From Figures 5.13 - 5.21 we observe that a large part of the features of OPRK1

dataset have similar distribution, which corresponds to conclusions about the nature
of features of ADORA2A dataset. Since the features are similar in nature in most of
these datapoints belong to class 0 label as the OPRK1 dataset is highly biased with
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(a) Histogram of pro mass

(b) Histogram of pro pl 3D

(c) Histogram of pro coeff fric

(d) Histogram of pro coeff diff

(e) Histogram of pro r gyr

(f) Histogram of pro r solv

Figure 5.13: Histogram of OPRK1 features (1-6).
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(a) Histogram of pro sed const

(b) Histogram of pro eccen

(c) Histogram of pro asa vdw

(d) Histogram of pro asa hyd

(e) Histogram of pro asa hph

(f) Histogram of pro volume

Figure 5.14: Histogram of OPRK1 features (7-12).
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(a) Histogram of pro mobility

(b) Histogram of pro helicity

(c) Histogram of pro henry

(d) Histogram of pro net charge

(e) Histogram of pro app charge

(f) Histogram of pro dipole moment

Figure 5.15: Histogram of OPRK1 features (13-18).
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(a) Histogram of pro hyd moment

(b) Histogram of pro zeta

(c) Histogram of pro zdipole

(d) Histogram of pro zquadrupole

(e) Histogram of pro patch hyd

(f) Histogram of pro patch hyd 1

Figure 5.16: Histogram of OPRK1 features (19-24).
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(a) Histogram of pro patch hyd 2

(b) Histogram of pro patch hyd 3

(c) Histogram of pro patch hyd 4

(d) Histogram of pro patch hyd 5

(e) Histogram of pro patch hyd n

(f) Histogram of pro patch ion

Figure 5.17: Histogram of OPRK1 features (25-30).
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(a) Histogram of pro patch ion 1

(b) Histogram of pro patch ion 2

(c) Histogram of pro patch ion 3

(d) Histogram of pro patch ion 4

(e)Histogram of pro patch ion 5

(f) Histogram of pro patch ion n

Figure 5.18: Histogram of OPRK1 features (31-36).
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(a) Histogram of pro patch neg

(b) Histogram of pro patch neg 1

(c) Histogram of pro patch neg 2

(d) Histogram of pro patch neg 3

(e) Histogram of pro patch neg 4

(f) Histogram of pro patch neg 5

Figure 5.19: Histogram of OPRK1 features (37-42).
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(a) Histogram of pro patch neg n

(b) Histogram of pro patch pos

(c) Histogram of pro patch pos 1

(d) Histogram of pro patch pos 2

(e) Histogram of pro patch pos 3

(f) Histogram of pro patch pos 4

Figure 5.20: Histogram of OPRK1 features (43-48).
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Table 5.8: Prediction of molecular conformations using three different sampling
strategies- KNN classifier.
Technique
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

%Training size
size
30

TP

TN

FN

FP

Acc

Precision

41

980

55

1024

48.6

0.03

70

20

493

18

369

57

0.05

30
70
30

37
17
0

1255
556
1997

59
21
96

749
306
7

61.5
63.6
95.5

0.04
0.05
0

70

3

843

35

19

94

0.13

(a) Histogram of pro patch pos 5

(b) Histogram of pro patch pos n

Figure 5.21: Histogram of OPRK1 features (49-50).
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class 0 samples. Therefore Table 5.7 and Table 5.8 gives us a very good detection
of TNs. We observe that the distribution of the identified features from the feature
selection techniques for OPRK1 dataset (From Section 4.4) are similar and since most
of the datapoints belong to class 0 labels hence we don’t have a good improvement in
detection of TPs.

5.2.3

Visualization of data patterns of OPRK1 dataset
In this section we understand the data patterns of OPRK1 dataset using

K-Means clustering technique. We performed elbow method on the entire dataset
to determine optimal number of clusters. From Figure 5.10 we can observe that the
optimal number of clusters chosen are 2. In order to visualize the data patterns we
had performed 2 methods:
• PCA followed by KMeans clustering
• t-SNE followed by KMeans clustering.
1. PCA followed by KMeans clustering:

From Figure 5.22 (a)-(b) we observe the data distribution of the datasamples
belonging to class 0 and class1. We observe that there is an overlap between the
data samples and majority of datasamples belong to class0 label. We later applied
PCA on the original training dataset and obtained the principle components such
that maximum amount of variance is preserved.
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Figure 5.22: Elbow method on original dataset-OPRK1

In Figure 5.22 (c)-(d) we observe that cluster1 contains less number of samples
and the data distribution is very sparse and contains many outliers. The number of
datasamples that cluster 1 contains are 800 whereas cluster2 contains 2199 datasamples.
It’s clearly seen that cluster2 conatins maximum number of datasamples and there is
no proper separation between the classes. The classes overlap and hence there is a
misclassification when we consider the entire dataset.
From Figure 5.22 we observe that the distribution of original data and feature
selection data are almost the same. The datsamples are sparse in cluster 1 and contain
more number of outliers.The number of datasamples in cluster 1 are 794 and in cluster
2 are 2205. So, that means feature selection is not contributing much information
in this case which this implies that the dataset needs some more datasamples that
belong to class 1 label with discrete features for a better performance.
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(a) Original dataset

(b) After PCA and K-Means

(c) PCA Reduced dataset

(d) After PCA and K-Means

Figure 5.23: Data distribution of ADORA2A before and after feature selection and
dimensionality reduction using PCA.

1. t-SNE followed by KMeans clustering:
The goal of using t-SNE is to reduce the overlap between the classes and increase
separation , because less overlap leads to less misclassification.
In Figure 5.23 (a)-(b) we observe that cluster1 contains more number of
samples and the data distribution of cluster 1 is dense and doesn’t contain outliers.
The number of datasamples that cluster 1 contains are 1965 whereas cluster2 contains
1034 datasamples. There is a less overlap between the classes in this case.
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(a) Original dataset using t-SNE

(b) After t-SNE and K-Means clustering

(c) t-SNE Reduced dataset using t-SNE

(d) After t-SNE and K-Means clustering

Figure 5.24: Data distribution of OPRK1 before and after feature selection and
dimensionality reduction using t-SNE.

From Figure 5.23 (c)-(d) we observe that cluster2 is dense and contain less
number of outliers.The number of datasamples in cluster 1 are 2055 and in cluster 2
are 944.
Overall, we can conclude from statistical distributions and data patterns of
OPRK1 dataset that the feature selection attributes doesn’t play a vital role in this
case because the dataset is highly biased towards class 0 labels.Therefore, removing
some features will definitely show some loss of information towards class one label.
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This has been further illustrated by performing the sampling strategies using only
feature selection attributes.
From Table 5.6 gives the per-class distribution in the testing dataset.

Table 5.9: Prediction of molecular conformations using three different sampling
strategies with Feature selection (FS)- GB classifier.
Technique
using FS
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

%Training
size
30

TP

TN

FN

FP

Acc

Precision

46

966

50

1038

48.1

0.04

70

22

351

16

511

41.4

0.04

30
70
30

26
15
34

1248
514
1433

70
23
62

756
348
571

60.6
58.7
69.8

0.03
0.04
0.05

70

15

609

23

253

69.3

0.05

Table 5.9 and Table 5.10 perform better than Table 5.7 and Table 5.8 on
maximizing the number of TNs for the cases Randomundersampling and SMOTE
but does’nt perform well in maximizing TPs. K-Means undersampling performs well
in maximizing TNs which further reduces FPs, but doesn’t give a good increase in
TPs because of which we have the same precision value. Overall, the methods have
the same precision, but when the methods are performed on the identified feature
selection attributes they perform excellent on maximizing TN. This is purely because
the dataset is highly biased towards class 0 lables and feature selection attributes
contribute more information towards class 0 labels. The reason behind having same
precision is because the dataset is highly biased and hence doesn’t contribute more
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in prediction of TPs. More number of datasamples belonging to class 1 labels with
discrete features could probably solve this problem.

Table 5.10: Prediction of molecular conformations using three different sampling
strategies- KNN classifier.
Technique
using FS
Random
Undersampling
Random
Undersampling
SMOTE
SMOTE
KMeansUndersampling
KMeansUndersampling

5.3

%Training
size
30

TP

TN

FN

FP

Acc

Precision

54

1021

42

983

51.1

0.05

70

22

431

16

431

50.3

0.04

30
70
30

41
12
34

1349
570
1433

55
26
62

655
292
571

66.1
64.6
69.8

0.05
0.03
0.05

70

15

609

23

253

69.3

0.05

Summary

In this chapter we had studied statistical distrubution and data patterns for
ADORA2A and OPRK1 datset. We had observed that the ADORA2A dataset had
similar features and performed less when compared to reduced dataset containing
feature selection attributes in terms of maximizing TPs. In this case, feature selection
attributes play a vital role in determining the Active Binding state of the conformations.
For OPRK1 datset, there wasn’t any significant improvement in terms of feature
selection attributes because the entire dataset is highly biased and removing features
would result in loss of information. Hence, more number of datasamples belonging
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to class 1 label with discrete features could probably solve this problem.In the next
chapter we will conclude our thesis.
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CHAPTER 6

CONCLUSION

The most fundamental goal in drug design is to predict how strongly a given
molecule binds to the target protein. MD simulations serve as an excellent basis
for validation and proof-of-concept of docking process, but when presented with
a new protein target that has no prior repository of known ligands (i.e. no prior
information), the likelihood that a particular protein conformation will be selected over
other conformations is not known. Thus, MD simulations do not provide data-driven
insights into the identification of data-patterns such as the bio-physical or chemical
properties of ligand at-large that enables the selection of specific target protein
conformations over the others. We had used advanced ML techniques to solve this
problem where we had determined a precise binding between the conformations and
the proteins by proposing a two-stage sampling-based classifier system which internally
uses random undersampling-SMOTE approach where LR+SMOTE-KNN model had
excelled in determining good number of TPs and TNs for both ADORA2A and OPRK1
datasets.
Although, the system predicted a good number of conformations, we wanted to
maximize the detection of the conformations and hence we also introduced K-Means
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clustering-based undersampling method. The motivation behind introducing this
method was to preserve highly important information corresponding to datasamples
belonging to class 0 label. Apart from predicting conformations we had also identified
the important features using feature selection techniques where they had identified the
features that play a vital role in determining the Active Binding state of conformations.
On implementing the system using K-Means undersampling method with feature
selection, the model had performed very well in maximizing the detection of TPs for
ADORA2A.
We also countered the class imbalance problem, maximized the detection of
potential drug-candidate conformations and non-drug candidate conformations using
the two-stage sampling-based classifier model. From ML perspective we had obtained
excellent detection of TPs using our proposed two-stage sampling based classifier.
We also delve deeper to understand the statistical distributions of data-patterns of
specific target protein conformations. From statistical distribution and data-patterns
we understood that the features of both the datasets are very similar in nature and
hence they were performing in the same way irrespective of the sampling strategy used.
Overall, greater number of datasamples with distinct features could probably solve this
problem. Feature selection played a vital role in this thesis work, where the selected
features maximize the detection of TPs for ADORA2A dataset and TNs for OPRK1
dataset, respectively. This work studied the effects of class imbalance problem and
designed a new comprehensive drug discovery system, which optimized the detection of
both non-drug candidate protein conformations that could be discarded and potential
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drug-candidate protein conformations that should be retained for further in-vitro
analysis.
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